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ABSTRACT 
The cardiomyocyte is a complex biological system where many mechanisms interact non-
linearly to regulate the coupling between electrical excitation and mechanical contraction. For 
this reason, the development of mathematical models is fundamental in the field of cardiac 
electrophysiology, where the use of computational tools has become complementary to the 
classical experimentation. My doctoral research has been focusing on the development of 
such models for investigating the regulation of ventricular excitation-contraction coupling at 
the single cell level. In particular, the following researches are presented in this thesis: 
 1) Study of the unexpected deleterious effect of a Na channel blocker on a long QT 
syndrome type 3 patient. Experimental results were used to tune a Na current model that 
recapitulates the effect of the mutation and the treatment, in order to investigate how these 
influence the human action potential. Our research suggested that the analysis of the clinical 
phenotype is not sufficient for recommending drugs to patients carrying mutations with 
undefined electrophysiological properties. 
 2) Development of a model of L-type Ca channel inactivation in rabbit myocytes to 
faithfully reproduce the relative roles of voltage- and Ca-dependent inactivation. The model 
was applied to the analysis of Ca current inactivation kinetics during normal and abnormal 
repolarization, and predicts arrhythmogenic activity when inhibiting Ca-dependent 
inactivation, which is the predominant mechanism in physiological conditions. 
 3) Analysis of the arrhythmogenic consequences of the crosstalk between β-adrenergic 
and Ca-calmodulin dependent protein kinase signaling pathways. The descriptions of the two 
regulatory mechanisms, both enhanced in heart failure, were integrated into a novel murine 
action potential model to investigate how they concur to the development of cardiac 
arrhythmias. 
 These studies show how mathematical modeling is suitable to provide new insights 
into the mechanisms underlying cardiac excitation-contraction coupling and 
arrhythmogenesis. 
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INTRODUCTION 
The term "excitation-contraction coupling" describes the fundamental electrophysiological 
process that links the electrical stimulation and the mechanical contraction in a muscle cell. 
Given the impact of heart diseases in the developed societies, a deep investigation of the 
mechanisms underlying cardiac excitation-contraction coupling and its derangements is 
extremely important. In the past 60 years, the research in cardiac electrophysiology has been 
benefiting from the use of mathematical models, now commonly adopted to support and drive 
the classical experimental work. Here, I will summarize the foundations of computational 
cardiac electrophysiology and provide with an outline of the subsequent chapters of this 
thesis. 
Historical development of experimental electrophysiology 
Electrophysiology is the branch of physiology that deals with the electrical properties of 
excitable cells and tissues (such as neurons and muscles). The history of this field dates back 
to the 17th century, when Jan Swammerdam first induced the contraction in a frog leg muscle 
by stimulating a nerve (Cobb, 2002). Swammerdam came close to understanding the nature of 
signal propagation between nerve and muscle, but at that time, the theory of electricity was 
still at its dawn. In fact, only about 100 years later, Benjamin Franklin, believed by many to 
be the "father of electricity", performed his famous experiment of flying a kite during a 
thunderstorm. At the end of 18th century, Luigi Galvani proposed his theory of electrical 
excitation of biological tissues (Galvani, 1791). He observed the relationship between 
stimulus density and muscle contraction, described the muscle refractoriness, and 
demonstrated the propagation of the stimulus, or action potential (AP). Galvani first 
hypothesized the existence of ion channels, described as water-filled channels penetrating into 
the fibers to allow excitability. Although the innovative concept of "animal electricity" 
proposed by Galvani has been initially countered by Alessandro Volta (a physicist known for 
the invention of the electric battery), it rapidly spread throughout Europe, also because of new 
findings by Giovanni Aldini, Galvani's nephew, which reinforced the theory of electrical 
excitation of biological tissue (Aldini, 1804) by studying the stimulation of body parts of 
freshly executed criminals. Furthermore, his experiments made a strong impact on the public 
opinion (Verkhratsky et al., 2006), inspiring even the famous Mary Shelley's "Frankenstein" 
(1817). 
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Table 1. Perspectives of historical development of electrophysiology. From (Verkhratsky et al., 2006; 
Luderitz, 2009; Priori, 2010). 
 
Year Event 
1660s Swammerdam pioneered the frog nerve muscle preparation. 
1790s Galvani developed the theory of electrical excitation of biological tissues, speculating about the existence of ion channels . 
1800s Aldini applied electrical currents to mammalian brains, reinforcing Galvani's theory. 
1828 Nobili instrumentally recorded animal electricity using an electromagnetic galvanometer  
1840s Matteucci demonstrated AP-induced muscle contraction, and measured the resting current between the intact and cut surface of the muscle potential. 
1848-1884 Du Bois-Reymond correctly interpreted Matteucci's experiments and refined the methods to record muscle currents from frogs and humans. 
1850s Von Helmotz determined the AP propagation speed along the nerve cell. 
1868 Bernstein made the first true recordings of resting and action potentials. 
1887 Waller first studied the electrical phenomena of the heart and recorded the first human ECG. 
1895 Langendorff pioneered the isolated perfused mammalian heart. 
1896-1902 
Nernst electrolytic theory has been adopted to explain the membrane 
excitability by Bernstein and Overton and it has been suggested that the 
AP results from the exchange of Na and K cations. 
1902 Einthoven developed the first practical ECG. 
1910s Morgan demonstrated that genes are carried on chromosomes and are the mechanical basis of heredity. 
1925 Gorter and Grendel found the bilayer structure of the cellular membranes. 
1930s Pioneering experiments on Chara and Nitella (algae in the family Characeae) by Harris, Osterhout, and Hill. 
1936 Young introduced the squid axon into physiological practice. 
1939 Cole and Curtis directly measured the giant squid axon AP by performing impedance measurements. 
1943 Hämmerling discovered the role of the nucleus as the repository of genetic information in eukaryotes. 
1944 Avery, McLeod and McCarty identified the molecule responsible for transformation as DNA. 
1949 Cole and Marmont developed the voltage-clamp technique. 
1952 Hodgkin and Huxley formulated the ionic theory of membrane excitation, and developed a squid axon AP model. 
1953 Watson and Crick determined the DNA double helix structure. 
1960 Noble developed the first cardiac AP model. 
1960s Nirenberg, Khorana and Holley discovered the genetic code. 
1963 Müller and Rudin measured ion currents in artificial lipid membranes. 
1976 Neher and Sakmann developed the patch-clamp technique. 
1977 Sanger developed the “chain termination” method for sequencing DNA. McAllister, Noble, and Tsien developed the first ventricular AP model. 
1980 Discovery of giga-seal between micropipette tip and surface cell membrane. 
1983 Mullis developed the polymerase chain reaction. 
1990s Development of species-specific ventricular AP models, and introduction of Markov models. 
1995 The Keating group identified mutations responsible for long QT syndrome. 
Computational Modeling of Cardiac Excitation-Contraction Coupling 
in Physiological and Pathological Conditions 
Stefano Morotti 3 
 During the following century many scientists gave important contributions to the 
progress of experimental electrophysiology (Table 1), both by developing new instruments 
and by providing novel interpretations of observed phenomena. Thus, by the mid-1930s, the 
fundamental features of AP were already known, the structure of the cell membrane was 
identified and the existence of ion channels suggested. The introduction of the giant squid 
axon into physiological practice allowed the first direct measures of APs by Cole and Curtis 
(Cole & Curtis, 1939), obtained by performing impedance measurements (first using 
extracellular, and then intracellular electrodes). About 10 years later, the voltage-clamp 
technique has been developed by Cole (Cole, 1949) and Marmont (Marmont, 1949), and 
applied by Hodgkin and Huxley to formulate the ionic theory of membrane excitation 
(Hodgkin & Huxley, 1952; Hodgkin et al., 1952), which demonstrated that membrane 
excitability is determined by passive ion fluxes, according to their electro-chemical gradients. 
The importance of their findings has also been recognized by the Nobel committee in 1963, 
when the Hodgkin and Huxley were awarded with the Nobel Prize in Physiology or Medicine. 
 Moreover, the Hodgkin and Huxley theory implied the existence of ion channel 
currents, whose instrumental recordings required to overcome several technical barriers, like 
the need to access mammalian cells, to control both the extra- and intracellular environments, 
and, above all, to deal with electrical signals characterized by a very small amplitude and a 
strong noise (Verkhratsky et al., 2006). The improvement in measurement techniques 
culminated with the development of the patch-clamp technique (Neher & Sakmann, 1976; 
Sigworth & Neher, 1980), which allowed the systematic measurement of ion currents and 
entirely new types of electrophysiological experiments. Patch-clamp technique became not 
only the workhorse of modern electrophysiology (Petersen et al., 2005), but also one of the 
most important techniques for the study of signal-transduction mechanisms. Thus, Neher and 
Sakmann, the developers of this technique, received the Nobel Prize in Physiology or 
Medicine in 1991. 
 The 20th century saw also the parallel development of modern genetics. Although 
genes were known to exist on chromosomes, only in the 1940s the role of DNA as molecule 
responsible for inheritance has been discovered. In 1953 Watson and Crick (then awarded 
with the Nobel Prize in Physiology or Medicine in 1962) determined the double helix 
structure of DNA (Watson & Crick, 1953), suggesting the fundamental mechanisms of DNA 
semi-conservative duplication (based on the separation of the two strands and the following 
reconstruction of two DNA filaments). How DNA influences the behavior of cells became 
clear only in the 1960s, when the studies of Nirenberg, Khorana and Holley (Nobel Prize in 
Physiology or Medicine in 1968) contributed to discover the role of RNA, messenger created 
from the DNA and responsible for protein synthesis (Rammler & Khorana, 1962; Nirenberg 
& Leder, 1964; Holley et al., 1965). With the understanding of the genetic code, the 
introduction of the Sanger method for sequencing DNA (Sanger & Coulson, 1975) and the 
development of the polymerase chain reaction for isolating and amplifying a specific section 
of a DNA (Mullis & Faloona, 1987), scientific research accelerated and, in late 1980s, the 
search for disease-causing mutations started. Like several other fields, electrophysiology has 
been strongly impacted by the innovation brought by these techniques (Priori, 2010). The 
search for the genetic bases of inherited arrhythmogenic diseases was initiated by the Keating 
group, that first identified genomic mutations able to disrupt structure and function of cardiac 
ion channels and to cause life threatening arrhythmias (Curran et al., 1995). Thus, the concept 
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of "cardiac channelopathies" emerged, leading to the redefinition of the paradigms for 
management of patients with inherited arrhythmogenic diseases. 
 Hodgkin and Huxley laid the foundation for the use of integrative models in biology, 
that have been progressively developed (and widely used) in the second half of 20th century. 
The close interplay between model development and experimentation, together with the 
improvement in laboratory instrumentations and the introduction of novel techniques (such as 
patch-clamp and genetic manipulation), led to the discovery of a great number of cellular 
structures and regulatory mechanisms, thus to a deeper comprehension of the behavior of the 
cardiomyocyte both in health and in disease (Grandi & Bers, in press). 
ECC in ventricular myocyte 
Cardiac excitation-contraction coupling (ECC) is the physiological process that links the 
electrical excitation of the membrane potential (Em) to the consequent mechanical contraction 
of the myocyte. ECC is mediated by Ca (Fig. 1, inset), an universal intracellular second 
messenger that is released in the cytosol at every beat to directly activate the myofilaments 
(Bers, 2001). 
 Under physiological conditions and in absence of excitation, ventricular cells maintain 
a relatively stable Em of about -85 mV (resting potential). When an excitatory stimulus 
depolarizes the membrane beyond the threshold potential (about -70 mV), an AP is produced 
(Fig. 1, inset). The AP is manifest as a propagating wave of transient depolarization (ten Eick 
 
 
 
Figure 1. Schematic representation of cardiac ECC. Main panel summarizes Ca transport mechanisms in 
ventricular myocytes; inset shows the time course of AP, CaT and contraction measured in a rabbit 
ventricular myocyte at 37°C. From (Bers, 2002). 
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et al., 1992), and arises as a result of the dynamic behavior of a diverse population of 
membrane ion channels. Thus, the AP is characterized by different morphologies across the 
regions of the heart (Fig. 2) and in different species. Ventricular AP in human (depicted in 
Fig. 3A) is similar to that in rabbit (Fig. 1, inset), and exhibits a steep upstroke (phase 0), 
followed by a brief steep repolarization (phase 1) and a sustained slowly decaying plateau 
phase (2). The plateau phase is followed by a steeper repolarization (phase 3) that restores the 
resting potential (phase 4) (Grandi & Bers, in press). 
 Depolarization to the threshold potential activates Na channels and results in a large 
Na current (INa, Fig. 3B), responsible for the AP upstroke, which quickly inactivates. Upon 
membrane depolarization, L-type Ca current (ICa, Fig. 3B) activates as well, but inactivates 
slowly and incompletely, allowing for the inward ICa to balance the outward K currents and 
maintain the plateau phase of the AP. About the 90% of the L-type Ca channels (LTCCs) are 
localized in the transverse-tubules (t-tubules), deep invaginations of the sarcolemma (Fig. 1), 
and this particular localization facilitates the Ca entered via LTCC to trigger the Ca release 
from the sarcoplasmic reticulum (SR). This phenomenon is called Ca-induced Ca release 
(CICR) and is mediated by the ryanodine receptors (RyRs), that are sensitive to Ca in the 
dyadic space (the space between t-tubules and SR). During diastole, most of the intracellular 
Ca is stored in the SR. Once CICR occurs, Ca is free to diffuse throughout the sarcomere, 
where it binds to the Ca binding protein troponin in the myofilaments and initiates cell 
contraction, then the SR actively resequesters Ca via the sarco/endoplasmatic reticulum Ca 
pump (SERCA). 
 Membrane repolarization is mainly due to various types of K currents (Fig. 3C): the 
transient outward currents (Ito and IClCa, carried by K and Cl respectively) determine the notch 
that follows the upstroke, the components of the delayed rectifier K current (IKr and IKs) 
 
 
 
Figure 2. AP waveforms in different regions of the heart. AP waveforms are displaced in time to reflect 
the temporal sequence of propagation through the heart (SA, sino-atrial node; AV, atrio-ventricular node; 
RV, right ventricle; LV, left ventricle). From (Nerbonne, 2000). 
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contribute to complete the repolarization, and the inward rectifier K current (IK1) maintains 
the resting potential. Ca entered the cell is extruded by Na-Ca exchanger (NCX), that yields a 
net inward charge movement (INaCa, Fig. 3D) when 1 Ca cation (divalent) is exchanged for 3 
Na cations (monovalent); also the plasma membrane Ca pump contributes to Ca extrusion and 
regulation of cytosolic intracellular [Ca] ([Ca]i). The Na-K pump (NKA) generates an 
outward current (INaK, Fig. 3D) by extruding 3 Na ions and importing 2 K cations 
(monovalent) on each cycle (Grandi & Bers, in press). 
 While Em influences [Ca]i, changes in [Ca]i and Ca transporters in turn alter Em. For 
example, the intracellular Ca transient (CaT) feeds back on the LTCC, mediating ICa 
inactivation, and therefore influences AP morphology. In pathological conditions, these 
mechanisms can also lead to triggered activity (Bers, in press), especially early and delayed 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic representation 
of ionic currents and CaT 
underlying the ventricular AP. 
Simulated (Grandi et al., 2010) human 
ventricular AP and CaT (panel A), Na 
and Ca currents (B, inset shows the 
different activation and decay times), 
K currents (C), and NKA and NCX 
currents. Modified from (Grandi & 
Bers, in press). 
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afterdepolarizations (EADs and DADs). EADs and DADs are abnormal depolarizations of the 
cell membrane (respectively occurring during AP phases 2 or 3, and during phase 4) 
associated to the development of cardiac arrhythmias. DADs usually occur in a condition of 
Ca overload, where an increased Ca leak from the SR triggers Ca extrusion via NCX, which 
depolarizes the membrane (Priori & Corr, 1990). The same mechanism has also been 
associated to phase 3 EADs (Luo & Rudy, 1994b), that are characterized by low take-off 
potential. Phase 2 EADs are typically observed when the APD is prolonged (e.g., IKr block or 
long QT syndromes), and are commonly associated to ICa reactivation during the prolonged 
plateau (January & Riddle, 1989; Luo & Rudy, 1994b; Zeng & Rudy, 1995). 
 Cardiac electrophysiology, contraction, metabolism, and gene regulation are also 
subject to modulation by a number of subcellular signaling pathways, which involve cascades 
of signaling molecules resulting in post-translational modifications (e.g., phosphorylation) of 
target proteins (Grandi & Bers, in press). One of the most widely studied signaling pathways 
is that induced by β-adrenergic (βAR) receptor stimulation, whose macroscopic effect is an 
enhancement of cardiac function. At the single cell level, βAR regulation of ECC is mediated 
by the phosphorylation of a wide spectrum of target proteins (Bers, 2002), including LTCC, 
RyR, and phospholamban (PLB, which controls SERCA activity), which leads to an 
enhancement of CaT (and thus contraction). Recently, Ca-calmodulin dependent protein 
kinase (CaMKII) has emerged as important in ECC regulation (Maier & Bers, 2007), and its 
overexpression has been associated to pathological phenotypes. Furthermore, CaMKII and 
βAR signaling pathways are closely interrelated, since they share some phosphorylation 
targets and, above all, βAR stimulation can directly or indirectly (via enhanced intracellular 
Ca) activate CaMKII. 
Modeling the mechanisms underlying ECC at the single cell level 
The cardiomyocyte is a complex biological system where many regulatory mechanisms 
interact with dynamically changing ionic concentrations and varying Em. These non-linear 
interactions make the single cell an interactive system where a high degree of synthesis and 
integration occurs (Rudy & Silva, 2006). Thus, analysis and synthesis of such complex 
systems can benefit from a mathematical approach. 
 The first computational AP model was formulated by Hodgkin and Huxley for the 
giant squid axon in 1952 (Hodgkin & Huxley, 1952; Hodgkin et al., 1952), and has been used 
as the basis to develop many modern neuronal and cardiac AP models. In Hodgkin and 
Huxley (H&H) model the inward movement of Na is responsible for the strong positive 
deflection of the Em observed in intracellular recordings, upon depolarization, while outward 
flow of K causes repolarization to the resting state. In this formulation the gating mechanisms 
regulate membrane permeability, whereby distinct entities (i.e. gates) controls the flux of both 
Na and K ions (Grandi & Bers, in press). 
 In the early 1960s Noble developed the first models of a cardiac myocyte AP (Noble, 
1960, 1962), adapting the H&H formulation to the Purkinje cell. Since ICa had not yet been 
discovered at that time, the plateau was supported by inward Na flux. LTCC model was 
introduced only in the 1975 (McAllister et al., 1975), and the idea that a balance between K 
and Ca currents maintains the plateau was reinforced in the first computational ventricular 
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myocyte model (Beeler & Reuter, 1977). Aspects of intracellular Ca handling were first 
introduced in the Purkinje cell in 1985 (DiFrancesco & Noble, 1985). In 1994 Luo and Rudy 
published a ventricular AP model (Luo & Rudy, 1994b, a) that included the intracellular SR 
compartment, time varying intracellular ion concentrations, and ion pumps and exchangers. 
The Luo-Rudy model (Luo & Rudy, 1994a) became one of the landmarks in the development 
of computational ventricular electrophysiology. Based on data recorded mostly in guinea pig, 
it was formulated using the traditional H&H scheme. 
 More recently, a large body of knowledge has been accumulated on the relationships 
between ion channel structure and function, the kinetic properties of single ion channels, and 
the modification of ion channel structure and function by genetic defects (Nickerson & 
Hunter, 2010). Thus, a major challenge has been the integration of new findings into the AP 
model in order to mechanistically relate molecular level findings to whole cell function, and it 
has become clear that models with explicit representation of single ion channel states are 
required. For this reason, Markov models have been adopted (Clancy & Rudy, 1999, 2002) to 
replace the H&H formulation (where the gating parameters do not represent specific kinetic 
states of ion channels). Markov models are based on the assumption that transitions between 
channel states depend on the present conformation of the channel, but not on previous 
behavior. As the molecular interactions of channels are often state-dependent, Markov model 
transitions typically represent specific channel movements that have been characterized 
experimentally (Rudy & Silva, 2006). 
 While most of the early AP models generically integrated experimental data from 
mammalian hearts (mostly guinea pig), many electrophysiological studies had shown species 
differences in AP waveforms and ionic currents. Thus, based on data obtained from isolated 
cells from one particular species, ventricular AP models have been developed for mouse 
(Bondarenko et al., 2004; Li et al., 2010), rat (Pandit et al., 2001), rabbit (Puglisi & Bers, 
2001; Shannon et al., 2004; Mahajan et al., 2008), and dog (Winslow et al., 1999; Greenstein 
et al., 2000; Hund & Rudy, 2004). The first human ventricular cell model was developed by 
Priebe and Beuckelmann (Priebe & Beuckelmann, 1998), adapting the major ionic currents of 
the Luo-Rudy model to the data available for human ventricular cells. More recently 
developed human models (Iyer et al., 2004; ten Tusscher et al., 2004; ten Tusscher & 
Panfilov, 2006; Grandi et al., 2010; O'Hara et al., 2011) included new measured data in 
human, providing a more accurate description of electrophysiological properties and Ca and 
Na handling in the human ventricular myocyte. 
 The Ca handling system was represented in the Luo-Rudy model by a 
phenomenological description (mimicking CICR) unable to capture the biophysical details 
involved (Grandi & Bers, in press). In 1998 Jafri et al. incorporated in a model of the guinea 
pig ventricular myocyte mechanistic Markov models for both LTCCs and RyRs and a 
restricted subspace (a single compartment representing the total volume of all dyads) into 
which all Ca fluxes through these channels are directed (Jafri et al., 1998). This "common 
pool" model, whereby sarcolemmal Ca influx enters the same Ca pool into which SR Ca is 
released and by which is regulated, cannot reproduce both high gain and graded release 
(Stern, 1992), that arises from local stochastic interactions between LTCCs and RyRs in 
thousands of Ca release units. In 2002 Greenstein and Winslow (Greenstein & Winslow, 
2002) developed a comprehensive model of the ventricular myocyte based on the theory of 
local control of SR Ca release. Another cytosolic Ca compartment (sub-sarcolemma) has been 
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then introduced (Shannon et al., 2004), based on experiments suggesting that NCX senses 
elevated Ca levels (compared to the bulk [Ca]), contributing to the improvement of Ca 
handling description. 
Thesis outline 
Nowadays computational models play an important role in electrophysiology research and 
their use is complementary to that of classical experimentation. The general purpose of a 
model is to translate a set of hypotheses into predictions of observable events, and these 
predictions can be compared to observations, and the underlying hypotheses can be rejected 
or corroborated (Potse, 2012). In the past 50 years, many mathematical models of cardiac AP 
have been developed for different mammalian species and different heart regions, and 
successfully applied to test whether and how the known mechanisms contribute for all the 
experimentally observed phenomena, to predict the effects on cell function induced by a 
mutation (Clancy & Rudy, 1999), or to understand under which circumstances a cell would 
contribute to arrhythmogenesis (Kurata et al., 2005). By coupling AP models together, it is 
possible to create tissue models in which study AP propagation and arrhythmia (Comtois et 
al., 2008). Furthermore, it is possible to study the effect of modified cardiac activation on 
cardiac pump function, by integrating the electro-mechanical coupling, mechanical 
contraction, mechano-electric feedback (Trayanova & Rice, 2011). 
 The present thesis will focus on the regulation of AP and Ca handling, which 
comprehension is essential to understand cardiomyocyte physiology and arrhythmogenesis 
(Bers, in press). I will describe three projects, in which computational models have been 
developed to investigate different mechanisms underlying ventricular ECC in different 
mammalian species, both in physiological and pathological conditions. 
 The next chapter will describe the use of computational modeling in a clinical context. 
The clinicians treated a patient presenting the phenotype of long QT syndrome type 3 (LQT3, 
an inherited arrhythmogenic disease) with a drug commonly used as a LQT3 gene-specific 
therapy. Unexpectedly, administration of the drug worsened the patient conditions, thus a 
deeper investigation of the effects of the specific mutation was needed. Our collaborators 
from the group of Dr. Silvia Priori (at the Salvatore Maugeri Foundation, Pavia, Italy, and 
Leon H. Charney Division of Cardiology, New York University School of Medicine, USA) 
performed the characterization in vitro, while we investigated in silico the effects of both 
mutation and drug administration on the corresponding gene/protein (encoding the cardiac Na 
channel) and on the human ventricular AP. 
 The second project focused on the study of the biophysical properties of ICa, which is 
one of the most important players in cardiomyocytes electrophysiology. The inactivation of 
this current is regulated by both Ca- and voltage-dependent inactivation mechanisms (CDI 
and VDI). Since the inhibition of both mechanisms has been associated to perturbed 
cardiomyocyte function, understanding of how CDI and VDI contribute to total inactivation is 
critical. Different strategies have been adopted in both experimental and theoretical studies to 
differentiate between the two mechanisms, and their accuracy is debatable. In collaboration 
with researchers from the group of Dr. Donald M. Bers (at the Department of Pharmacology, 
University of California in Davis, USA), we analyzed those strategies to select the most 
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accurate one. Based on this, we identified and validated an improved model of LTCC 
inactivation in rabbit ventricular myocyte, which was applied to study the relative roles of 
CDI and VDI during normal and abnormal repolarization. 
 The third chapter will present a study carried out in the Bers Lab in collaboration with 
researchers from the group of Dr. Andrew D. McCulloch (at the Department of 
Bioengineering, University of California in San Diego, USA), with the aim of investigating 
the crosstalk between CaMKII and βAR signaling pathways in the context of heart failure 
(HF). It has been shown that both CaMKII expression and βAR tone are upregulated in HF, 
thus it is important to understand how their interaction could contribute to ECC regulation and 
arrhythmogenesis. To this aim, we developed a model of murine ventricular ECC, where 
descriptions of Ca, βAR and CaMKII signaling pathways are integrated. The use of transgenic 
mouse models has proven to be particularly appropriate in the context of HF, given the wealth 
of experimental data that can be measured in mice, but cannot be obtained as easily in 
humans. Our work established the basis for the development of a systematic framework that, 
accounting for electrophysiological differences among species, is necessary to extrapolate 
findings in the genetically engineered mouse to the most relevant clinical setting. 
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CHAPTER 1 
Trafficking Defects and Gating Abnormalities of a 
Novel SCN5A Mutation Question Gene-Specific 
Therapy in Long QT Syndrome Type 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Short title: Paradoxical Effect of Mexiletine on LQT3. 
___________________________________________________________________________ 
The content of this chapter has been published in: 
 
Ruan Y, Denegri M, Liu N, Bachetti T, Seregni M, Morotti S, Severi S, Napolitano C & 
 Priori SG. (2010). Trafficking defects and gating abnormalities of a novel SCN5A 
 mutation question gene-specific therapy in long QT syndrome type 3. Circulation 
 Research 106, 1374-1383. 
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Abstract 
Na channel blockers are used as gene-specific treatments in long QT syndrome type 3 
(LQT3), which is caused by mutations in the Na channel gene (SCN5A). The response to 
treatment is influenced by biophysical properties of mutations and we sought to investigate 
the unexpected deleterious effect of mexiletine in a mutation combining gain-of-function and 
trafficking abnormalities. A LQT3 child experienced paradoxical QT prolongation and 
worsening of arrhythmias after mexiletine treatment. The SCN5A mutation F1473S expressed 
in HEK293 cells presented a right-ward shift of steady-state inactivation, enlarged window 
current, and huge sustained Na current (INa). Unexpectedly, it also reduced INa peak by 80%. 
Immunostaining showed that mutant NaV1.5 is retained in the cytoplasm. Incubation with 10 
µmol/L mexiletine rescued the trafficking defect of F1473S, causing a significant increase in 
peak current, whereas sustained current was unchanged. Using a INa Markov model and a 
model of human ventricular action potential (AP), we showed that simulated exposure of 
F1473S to mexiletine paradoxically increased AP duration, mimicking QT prolongation seen 
in the index patient on mexiletine treatment. We provided evidence that Na channel blockers, 
which are largely used to shorten QT intervals in carriers of SCN5A mutations, may facilitate 
trafficking of mutant proteins, thus exacerbating QT prolongation. These data suggest that 
caution should be used when recommending this class of drugs to carriers of mutations with 
undefined electrophysiological properties, and in vitro and in silico analysis may help to 
choose the proper treatment. 
INTRODUCTION 
Long QT syndrome (LQT) is an inherited arrhythmogenic disease characterized by QT 
interval prolongation and susceptibility to ventricular tachyarrhythmias. LQT type 3 (LQT3) 
is a variant of LQT characterized by high lethality (Priori et al., 2003), marked prolongation 
of repolarization, poor response to β-blockers (Priori et al., 2004), and cardiac events 
occurring preferentially at rest. LQT3 is caused by mutations in the SCN5A gene that encode 
for the α subunit of the channel that conducts the inward Na current (INa) responsible for fast 
depolarization and critical for maintenance of intracardiac conduction (Clancy & Kass, 2005; 
George, 2005). Following the identification of the first SCN5A mutation published in 1995 
(Wang et al., 1995), more than 80 SCN5A mutations have been identified in LQT3 patients. 
 SCN5A mutations associated with LQT3 increase INa by augmenting either the 
sustained current (Isus) or the window current, thus prolonging cardiac repolarization (Ruan et 
al., 2009). Based on this evidence, the use of Na channel blockers to treat LQT3 patients and 
reduce QT interval has been proposed. Early in vitro studies (Priori et al., 1996) demonstrated 
that mexiletine is effective in shortening action potential duration (APD) in cardiac myocytes 
exposed to anthopleurin, a compound that mimics LQT3 cellular phenotype. Furthermore 
early clinical studies on the use of mexiletine or flecainide were successful in shortening 
repolarization (Schwartz et al., 1995; Windle et al., 2001) and paved the way to the clinical 
use of Na channel blockers in LQT3 patients as a gene-specific therapy. 
 As the experience with the use of these drugs accumulated, the early enthusiasm was 
dimmed, and it became clear that flecainide might not be always appropriate for LQT3 
patients. Indeed, the response of selected mutations could induce an electrocardiographic 
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pattern of coved type ST segment elevation in right precordial leads typical of Brugada 
syndrome (Priori et al., 2000; Makita et al., 2008). Shortly thereafter, it also became clear that 
Na channel blockers do not invariably shorten the QT interval, suggesting that SCN5A 
mutations act through other mechanisms, questioning the "gain-of-function" paradigm that all 
LQT3 mutations lead to a common channel dysfunction. 
 This view is supported by the fact that "some" SCN5A mutations cause "overlapping 
syndromes" in which QT prolongation is associated with "loss-of-function" clinical 
phenotypes (Brugada syndrome or conduction defects) (Bezzina et al., 1999; Grant et al., 
2002; Antzelevitch et al., 2005). It has been recently demonstrated that biophysical diversity 
of SCN5A mutations is a determinant of response to mexiletine in the clinical setting (Ruan et 
al., 2007). 
 Here, we bring the characterization of the diversity of SCN5A mutations to the next 
level by showing that the interplay between protein trafficking and biophysical abnormalities 
may detrimentally affect the response to Na channel blockers and represent a hazard rather 
than a cure. 
 
 
 
 
 
 
Figure 1. Mexiletine failed to shorten QTc and to prevent malignant ventricular arrhythmia. Panel A, 
DNA sequence encoding a portion of DIII~DIV is shown for a normal control and for the index patient. The 
affected codon is enclosed by a rectangle indicating the heterozygous F1473S missense mutation. B, ECG 
recorded at day 1 (upper trace) and day 10 (lower trace) of mexiletine treatment. Further QTc prolongation is 
evident and T wave is almost fused with the subsequent stimulation spike. C, ECG tracing recorded at day 10 
on mexiletine showing failures of pacemaker capture with extremely prolonged cardiac repolarization. 
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METHODS 
In vitro characterization has been performed by our collaborators from Priori group, while we 
investigated in silico the consequences of mutation and mexiletine administration on the 
human ventricular action potential (AP). 
In vitro 
Molecular Screening 
Genetic analysis was performed by screening of the open reading frame of the SCN5A, 
KCNH2, KCNQ1, KCNE1, and KCNE2 genes as previously reported (Napolitano et al., 
2005). 
Site-directed Mutagenesis and Transfection in HEK293 Cells 
The SCN5A mutations were engineered into wild-type (WT) cDNA cloned in pcDNA3.1 
(Invitrogen, Carlsbad, CA, USA) and confirmed by sequence analysis of the entire cDNA of 
 
 
 
Figure 2. Gating properties of F1473S. Panel A, The voltage dependence of SSI and SSA of F1473S, 
measured with standard pulse protocols shown in inset. B, Recovery from inactivation was assessed by the 
double-pulse protocol shown in inset and fitted using a biexponential function. C, Representative current 
traces evoked by 150 ms pulses to -10mV for cells expressing WT or F1473S channels. Currents have been 
normalized to facilitate comparison of WT and F1473S current traces. Besides reduced peak current, F1473S 
impair channel inactivation and induce a huge Isus. D, The amplitude of Isus in F1473S expressed in 
percentage of peak current is more than 20-fold larger than in WT; and it is also significantly larger than in 
P1332L, S941N, R1626P and M1652R, the LQT3-causing SCN5A mutations previously studied. N=7 to 21 
cells for each group. * P < 0.001 compared with WT, P1332L, S941N, R1626P and M1652R. E, WT and 
F1473S currents in response to a ramp test. 
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SCN5A. HEK293 cells were transfected with equal amount of Na channel α and β1 subunit by 
lipofectamine as previously described (Ruan et al., 2007). 
Electrophysiology 
Membrane currents were measured using whole-cell patch-clamp procedures, with Axopatch 
200B amplifiers (Axon Instruments, Foster City, CA, USA). Internal pipette solution 
contained (mmol/L) aspartic acid 50, CsCl 60, Na2-ATP 5, EGTA 11, HEPES 10, CaCl2 1, 
and MgCl2 1, with pH 7.4 adjusted with CsOH. External solutions consisted of (mmol/L) 
NaCl 130, CaCl2 2, CsCl 5, MgCl2 1.2, HEPES 10, and glucose 5, with pH 7.4 adjusted with 
CsOH. In experiments designed to measure the voltage dependence of activation, external Na 
was reduced to 30 mmol/L with N-methyl-glucamine used as a Na substitute. Recordings 
were made at room temperature. Holding potentials were -100 mV. Isus was measured 150 ms 
 
 
 
Figure 3. F1473S induced a large Isus and reduced peak current in SCN5A channel. Panel A, 
Representative whole-cell current traces in HEK293 cell expressing WT (upper) and F1473S (middle) 
channels. Lower: Current-voltage (I-V) relationship of peak inward current. B, Cells expressing either WT 
(left) or F1473S (right) SCN5A were immunostained with anti-SCN5A primary antibody (Alomone ASC-
005, green). The nuclei were highlighted by the DAPI staining (blue) (scale-bar 10 nm). WT channels were 
distributed mainly in the cytoplasm and on the plasma membrane; F1473S mutant channels show many 
condensed spots within the cytoplasm, suggesting a trafficking impairment (white arrows). C, Cytoplasmic 
distribution of F1473S mutant channel in HEK-SCN5A stable cell lines. Fixed cells were co-stained with the 
anti-SCN5A polyclonal antibody (green, a and d) and either with anti-Calnexin mAb for the ER (red, b) or 
anti-Golgin 97 mAb for the Golgi Apparatus (red, e). Protein localization was revealed by indirect 
immunofluorescence using DyLight 488-conjugated anti-rabbit IgG donkey antibodies and DyLight 594-
conjugated anti mouse IgG donkey antibodies. The nuclei were stained with DAPI (blue) (scale-bar 10 
nm).F1473S showed many condensed spots (white arrows) proximal to and partially co-localizing with the 
ER but not with the Golgi apparatus revealing that F1473S mutant channels are either kept in the ER or in 
the cytoplasm. 
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after depolarization to -10 mV and determined by subtracting background currents measured 
in the presence of tetrodotoxin (30 μmol/L, Sigma) from tetrodotoxin-free records. This 
subtraction procedure was also used for voltage ramp experiments. Steady-state inactivation 
(SSI) was determined after application of conditioning pulses (500 ms) applied to a series of 
voltages with an interpulse interval of 5 seconds for control and 30 seconds for mexiletine. 
Steady-state activation (SSA) was estimated by measuring peak current during a variable test 
potential. Current at each membrane potential was divided by the electrochemical driving 
force for Na ions and normalized to the maximum Na conductance. Data for the voltage 
dependence of activation and inactivation were fitted with the Boltzmann equation. Recovery 
from inactivation was measured in paired pulse experiments. Details of pulse protocol are 
given schematically in the figures. Data for the time course of recovery were fitted with 
biexponential function. Tonic block was measured at 0.033 Hz after steady-state was 
 
 
 
Figure 4. Rescue effect and block effect of mexiletine. Panel A, Tonic block for WT, R1626P (mexiletine 
sensitive), S941N (mexiletine insensitive), and F1473S, determined by the first test pulse after application of 
mexiletine. B, F1473S depolarizing shift SSI produced an enlarged window current (black solid line) 
compared with WT (block dash line); effect of 10 µmol/L mexiletine on window current was marked as grey 
solid line. C, Peak current density of three conditions: F1473S control (control, 20.54±2.22 pA/pF at -5mV, 
n=33), F1473S incubated with 10 µmol/L mexiletine for 48 hours with current recording without the drug 
(w/out tonic block, 29.17±2.87 pA/pF at -5mV, n=44, P<0.05 vs. control), and F1473S incubated with 10 
µmol/L mexiletine for 48 hours and current recording in the presence of mexiletine (mex w/ tonic block, 
27.17±2.3 pA/pF at -5mV, n=36, P<0.05 vs. control). D, Isus density of three conditions: F1473S control, 
F1473S incubated with 10 µmol/L mexiletine for 48 hours with current recording without (and with) the 
drug. 
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achieved in the presence of mexiletine. In drug rescue experiments, freshly prepared 10 
μmol/L mexiletine was added to the culture media. 
Immunofluorescence 
For immunofluorescence (IF) experiments HEK293 cells were seeded on 0.1% gelatincoated 
coverslips and allowed to attach for 24 h, where indicated 10 μmol/L mexiletine was added 
for 48 hours. Following PBS washed cells were fixed with 4% PFA for 10 min and 
permeabilised with 0.2% Triton for 10 min. Blocking of unspecific sites were achieved by 
incubation with 10% BSA for 1 hour at room temperature. Primary antibodies used were: 
polyclonal NaV1.5 (Alomone, ASC-005, 1:100), monoclonal Calnexin (Alexis, clone AF18, 
1:200), monoclonal Golgin 97 (Molecular Probes, CDF4, 1:50). Secondary antibodies used 
were: DyLight 488-conjugated donkey anti-rabbit IgG and Dy-Light-conjugated 594-
conjugated donkey anti-mouse IgG (Jackson Laboratories, 1:100). The coverslips were then 
mounted using a DAPI-containing mounting medium (Vectashield, Vector Laboratories, 
Burlingame, CA, USA). Confocal microscopy was performed with a Leica TCS-SP2 digital 
scanning confocal microscope equipped with a HCX PL APO 40x/numerical aperture=1.25 
oil immersion objective. The 488-nm Argon laser line has been used for excitation of DyLight 
488-conjugated donkey anti-rabbit IgG (detected at 500-530 nm) and the 594 nm He/Ne laser 
 
 
 
Figure 5. Rescued membrane expression of F1473S SCN5A channel with 10 µmol/L mexiletine. Panel 
A, mexiletine incubation increased the cytoplasmic distribution of F1473S and released the intracellular 
condensed spots of F1473S (scale-bar 20 nm). B, Confocal images of F1473S distribution with phase 
contrast in control condition (upper) and with 10 µmol/L mexiletine incubation (lower) (scale-bar 10 nm). C, 
Plasma membrane fraction of F1473S SCN5A was increased by mexiletine incubation. PM indicates plasma 
membrane, Cyt, cytosol, CL, total cell lysate; Con, control, no mexiletine incubation, Mex, 10 µmol/L 
mexiletine incubation for 48 hours. β-Actin was used as the normalizing control. 
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line for excitation of Dy-Light-conjugated 594-conjugated donkey anti-mouse IgG (detected 
at 580-630 nm). The pinhole diameter was kept at Airy 1. Images were exported to Adobe 
Photoshop (Adobe Systems, Mountain View, CA, USA). 
Immunoblotting for Quantification of Plasma Membrane Protein Expression 
First our collaborators confirmed that the INa observed in stable cell lines expressing F1473S-
NaV1.5 was identical to the current observed in cells with transient expression of the mutant α 
and β1 subunit and they were able to show that the same large Isus, reduced peak current, 
trafficking defect and gating properties were also present in the transiently transfected cells 
expressing F1473S-NaV1.5 (data not shown). HEK293 cells which stably expressed F1473S 
SCN5A were lysed and total proteins extracted; plasma membrane and cytosolic fractions 
were isolated using a plasma membrane protein extraction kit according to manufacturer's 
instructions (Biovision). Total proteins (15 micrograms/sample, quantified by the BCA assay) 
were resolved by SDS-gel electrophoresis on Novex 4-12% BisTris gradient gels using MES-
SDS buffer (Invitrogen), and blotted on nitrocellulose membranes using a submarine system 
(Invitrogen). A monoclonal anti-human NaV1.5 antibody (1:500, Alomone, Asc-005) was 
used to probe for the Na channel while a polyclonal anti β-Actin antibody (1:5000, Affinity 
Bioreagents) was used to detect a reference protein. Secondary antibodies were conjugated 
with HRP (1:3000, Promega). Mouse heart was used as positive control. Specific signals were 
developed using the Supersignal West Pico Chemiluminescent substrate (Pierce) and detected 
using X-ray films (Kodak). 
Statistics 
Pclamp9.2 (Axon Instruments, Foster City, CA, USA) and Excel (Microsoft, Seattle, WA, 
USA) were used for data acquisition and analysis. Data are presented as mean values ± S.E. 
Statistical comparisons were made using an unpaired 2-tailed t-test or ANOVA with the 
Tukey post hoc test to evaluate the significance of differences between means. P<0.05 was 
considered statistically significant. 
 
 
 
 
Figure 6. Markov model of the cardiac Na channel. The channel model contains background 
(upper nine states) and burst (lower four states) gating modes. The burst mode reflects a population 
of channels that transiently fail to inactivate. From (Grandi et al., 2007). 
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In silico 
The Na channel Markov model was based on the structure originally proposed by Clancy and 
colleagues (Clancy & Rudy, 1999; Clancy et al., 2002), depicted in Fig. 6. The whole-cell INa 
is given by: 
)( NamONaNa EEPGI  , 
where the variable PO represents the sum of the probabilities to be in the open states (O and 
LO), Em is the membrane potential, ENa is the Na Nerst potential and GNa is the maximum 
conductance. The expressions of the transition rates are reported in Table 1. The transition 
rate parameters were identified by a manual fitting procedure to simulate the experimental 
data of whole-cell cardiac INa from HEK cells expressing WT or F1473S SCN5A. The 
following voltage-clamp protocols were simulated for parameter identification: SSA and SSI, 
recovery from inactivation, positive voltage ramp and long-depolarization voltage step to 
assess Isus. The model results for each protocol were compared with experimental data. The 
parameter values proposed by in a previous study (Grandi et al., 2007) were chosen where 
possible as initial guesses in the identification procedure of the transition rate parameters that 
allowed the best fitting of our WT data. We modified a2 and a4 to reproduce the experimental 
data on SSA; a5 was tuned to correctly simulate the channel availability curve; a6, b6 and a7, b7 
were adjusted to represent the observed characteristics of recovery from inactivation, a5, b6, b7 
were modified to reproduce the response to voltage ramp in the mutant channels and the ratio 
a8/b8 was tuned to reproduce the experimental data accounting for Isus. The identified WT set 
was subsequently used as initial guess to identify the F1473S channel parameters, and two 
parameters of the F1473S set were tuned to reproduce the effect of mexiletine treatment: P2a5 
was modified to introduce the SSI shift and P1a8 to reduce Isus. Table 2 reports the three sets of 
model parameters. 
 We integrated the INa model into a model of AP in human epicardial ventricular 
myocyte (ten Tusscher & Panfilov, 2006) as modified by Severi et al. to correctly reproduce 
 
 Table 1. Na channel model transition rate expressions. 
 
Transition rate expressions 
a1 = P1a1 /(1+exp((-Em+P2a1)/P3a1))
a2 = P1a1 /(1+exp((-Em+P2a2)/P3a2))
a3 = P1a3 /(1+exp((-Em+P2a3)/P3a1))
b1 = P1b1 exp((-Em+P2a1)/P2b1)
b2 = P1b2 exp((-Em+P2b2)/P2b1)
b3 = P1b3 exp((-Em+P2b3)/P2b1)
a4 = P1a4 exp((Em-P2a1)/P2a4)
a5 = (P1a5 /(1+exp((Em+P2a5)/P3a5)))(P7a5+P4a5 /(1+exp((-Em+P5a5)/P6a5))) 
a6 = a4/P1a6 
b4 = (a3 a4 a5)/(b3 b5) 
b5 = P1b5 +P2b5 (Em-P2a1)
b6 = P1b6 exp((-Em+P2a1)/P2b6)+P5b6 /(1+exp((-Em+P4b6)/P3b6)))
a7 = P1a7 exp((Em-P2a1)/P2a7)
b7 = P1b7 exp((-Em+P2a1)/P2b7)+P5b7 /(1+exp((-Em+P4b7)/P3b7)))
a8 = P1a8 
b8 = P1b8 
 
Paradoxical Effect of Mexiletine on LQT3 
24 Ph.D. Thesis 
the experimental APD inverse dependence on extracellular [Ca] (Severi et al., 2009). The 
kinetic rates were normalized to 37°C using a Q10 of 2.1 (Maltsev & Undrovinas, 2006). 
Extracellular [Ca] was set to the physiological value of 1.15 mmol/L. Since mutant patients 
reveal stronger Isus and thereby higher intracellular [Na], the initial value of this concentration 
was set at 15 mmol/L in order to reach quickly the steady-state condition. Pacing was 
simulated by a current pulse train (pulse 1 ms duration, 52 pA/pF amplitude) at different 
frequencies (from 30 to 120 bpm, i.e. from 0.5 to 2 Hz). The stimulation was maintained at 
 
 Table 2. Na channel model parameters for WT and F1473S. 
 
Parameters WT 
F1473S 
 + mexi 
P1a1 62.5 25
P2a1 5.4e-3
P3a1 15 30
P2a2 -5.4e-3 -6.0054
P3a2 17 7
P1a3 500 27
P2a3 29.995 -5.4e-3
P1b1 0.47925 0.1917
P2b1 20.3
P1b2 0.5 0.2
P2b2 4.9946
P1b3 0.55 0.22
P2b3 9.9946
P1a4 1.175 5.1
P2a4 90 45
P1a5 0.021 0.265
P2a5 71.995 56.995 57.995
P3a5 6
P4a5 0 400
P5a5 29.995
P6a5 7
P7a5 1
P1b5 0.126 0.42
P2b5 2e-6
P1a6 50 17
P1b6 3e-4
P2b6 11.394 13
P5b6 0 0.25
P3b6 5
P4b6 -18.005
P1a7 3.543e-3 3.19e-3
P2a7 23.27
P1b7 8 5.8363 e-5
P2b7 35.99 27
P3b7 3
P4b7 -30.005
P5b7 0 4.5e-3
P1a8 1.4e-6 4.9e-6 1.5e-6
P1b8 9.5e-4
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least for 200 s. To analyze the effects of mutations on cardiac AP in the heterozygous 
condition of F1473S patients, we replicated conditions with different percentage of mutant 
and WT Na channels. 
 Matlab and Simulink (Mathworks, Natick, MA, USA) were used for all the numerical 
computations. A variable order solver based on the numerical differentiation formulas (NDFs) 
was used to numerically solve the model equations (ode15s). 
RESULTS 
Clinical history of the carrier of F1473S mutation in the SCN5A gene 
The mutation here characterized was identified in a patient born in 2003; no ECG was 
recorded at birth, and the baby was discharged as a healthy infant. At 12 months of age, he 
experienced 5 syncopal spells within a few days, was hospitalized and long QT syndrome was 
diagnosed. Propranolol (4 mg/kg per day) was initiated, and a blood sample was sent to the 
Priori group in Maugeri Foundation for genetic screening. They sequenced the opening 
reading frame of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 and identified a 
heterozygous single-nucleotide transition (4418T>C) in the SCN5A gene, leading to a single 
amino acid replacement at position 1473 (F1473S, Fig. 1A). This mutation was not present in 
either the parents of the index case or in 300 control DNA samples. 
 The patient remained asymptomatic for 2 years on β-blockers; however, in 2006, 
syncope recurred and torsade de pointes was documented; a ventricular-inhibited pacemaker 
was implanted, and the dose of β-blockers was increased. One year later, the patient 
experienced another syncopal episode, accompanied by several runs of torsade de pointes. 
Oral mexiletine was started in an attempt to shorten QT interval and to control arrhythmias; 
sinus rhythm was regained and QT duration appeared stable at day 1 of administration (Fig. 
1B, upper trace); unfortunately, the effect of mexiletine (60 mg tid) decayed as the treatment 
continued. After 10 days, corrected QT interval (QTc) persistently exceeded 650 ms (Fig. 1B, 
lower trace); furthermore, progressive worsening of intraventricular conduction with QRS 
widening, and occasional pacemaker capture failures (Fig. 1C) were observed. At day 11, the 
patient developed incessant, intractable tachyarrhythmias and died. The clinicians who treated 
the patient were confounded by the worsening clinical status during mexiletine treatment. The 
inspection of the available ECG showed QTc shortening just at the beginning of therapy 
followed by prolongation (Fig. 1B). The Priori group and us attempted to understand this 
uncommon and paradoxical response to mexiletine by functional characterization of the 
mutant. 
Functional in vitro characterization of F1473S mutation 
As shown in Fig. 2A, F1473S depolarized the SSI curve by 18.9 mV and SSA curve by 4.4 
mV. The SSI pattern of mutant channels was consistent with previous observations (Ruan et 
al., 2007) showing that mexiletine-insensitive mutations are those causing a depolarizing shift 
of SSI and it also produced a greater overlap of activation and inactivation relations. As a 
consequence, the window current was markedly enhanced. Recovery from inactivation is 
shown in Fig. 2B. 
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 Besides enlarged window current, F1473S showed a striking increase of Isus. At -10 
mV, F1473S channels continued to show 4.46±0.74 pA/pF (5.39±0.2% of the peak current) at 
150 ms as compared to 0.64±0.22 pA/pF (0.25±0.05%) in WT (P<0.0001). Overall, F1473S 
showed a much higher Isus than other mutations previously characterized (Ruan et al., 2007) 
(Fig. 2C). 
 Our collaborators further characterized the gain-of-function behavior by ramp voltage 
protocol (from -100 mV to +50 mV). F1473S conducted larger peak currents than WT 
(F1473S -6.38±0.71 pA/pF, n=9 vs. WT -2.28±0.14 pA/pF, n=8; P<0.0001), and the voltage 
of the peak was shifted by about +20 mV (F1473S -17.1±3.5 mV, n=9 vs. WT -37.8±3.1 mV, 
n=8; P<0.0001). WT channels conduct current over a narrow range of voltages near -37 mV, 
whereas F1473S mutant channels conduct current over a broad range of voltages and increase 
the inward INa (Fig. 2D). The Priori group concluded that the remarkable increase of both the 
window current and the Isus account for QT prolongation and the malignant clinical 
phenotype. 
 On the other hand, F1473S peak current density was unexpectedly reduced to 20% of 
 
 
 
Figure 7. Experimentally determined and simulated effects of F1473S mutation on Na channel 
properties. Panel A, SSI and SSA, the inset highlights in silico results in window current region. B, 
recovery from inactivation. Dots represent data from in vitro experiments, solid lines represent simulated 
results. C, experimental (black) and simulated (white) ratio between sustained and peak current for WT and 
F1473S channels. D, experimental (symbols) and simulated (solid lines) I-V relations for WT and F1473S 
channels. 
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WT (Fig. 3A), suggesting a trafficking abnormality. This hypothesis was confirmed by 
confocal microscopy experiments that showed an abnormal protein distribution characterized 
by clusters/aggregates retained in the cytoplasm (Fig. 3B, F1473S). Our collaborators 
attempted to colocalize such clusters to determine whether the mutant polypeptides were 
retained either in the endoplasmic reticulum (ER) (anti-calnexin antibody) or in the Golgi 
apparatus (anti-Golgin antibody). The F1473S-NaV1.5 clusters did not colocalize with Golgi 
(Fig. 3C, f) and only mildly colocalized with ER (Fig. 3C, c), suggesting that most of the 
abnormal protein is likely to be either free in the cytosol or segregated in yet unidentified 
subcellular domain(s). 
 
 
 
 
 
Figure 8. Simulated WT and F1473S current response to positive and negative 
voltage ramp protocols. Panel A, experimental (from Fig. 2E) and simulated WT and 
F1473S current obtained in response to a positive ramp test. B, simulated WT and F1473S 
current obtained in response to a negative ramp protocol. 
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Response of F1473S-NaV1.5 channel to exposure to Na channel blockers 
Our collaborators compared the tonic block of mexiletine in F1473S-NaV1.5 with that 
observed in WT and in mexiletine-sensitive (R1626P) and mexiletine-insensitive mutations 
(S941N) previously characterized (Ruan et al., 2007). Fig. 4A shows that tonic block of peak 
current with 10 µmol/L mexiletine was significantly higher in R1626P compared with WT, 
S941N, and F1473S; no significant difference was found between F1473S and WT or the 
insensitive mutation, S941N. Consistent with previous studies showing that Na channel 
blockers inhibit preferentially Isus vs. peak current (Wang et al., 1997), tonic block of Isus was 
proportionally stronger than tonic block of peak current with 10 µmol/L mexiletine (Fig. 4A). 
The tonic block of Isus was similar among the 3 mutants. 
 An additional well-known mechanism underlying the LQT3 phenotype is the 
reopening of Na channels over voltage ranges for which SSI and SSA overlap (i.e. the 
window current). The Priori group tested the effect of 10 µmol/L mexiletine on SSI and SSA 
in the F1473S mutation. SSI shifted toward the negative potential by -1.15 mV, SSA was 
slightly shifted toward the positive potential by 0.32 mV leaving the overlapping region 
substantially unchanged (Fig. 4B). 
Mexiletine exposure and trafficking 
Previous studies suggested mexiletine rescued impaired trafficking observed in selected loss-
of-function SCN5A mutants associated with Brugada syndrome (Valdivia et al., 2002; Tan et 
al., 2006; Pfahnl et al., 2007). Our collaborators therefore assessed whether the F1473S-
Nav1.5 trafficking defect could be rescued by the drug. F1473S channels incubated with 
mexiletine (10 µmol/L for 48 hours) did not change their gating properties (data not shown) 
but showed significantly increased current density. Fig. 4C shows that INa peak at -5 mV 
increased by 42% after incubation but recorded in the absence of mexiletine, indicating that 
mexiletine does restore trafficking of F1473S. Interestingly, however, peak current density 
recorded in the presence of mexiletine (after incubation) was still increased by 32%, 
indicating that rescue effect overwhelmed the blocking effect. 
 
 
 
 
Figure 9. Simulated impact of increasing F1473S mutation expression 
on AP. APD increases when increasing the expression of mutant channel. 
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 Similar approach was used to quantify Isus: 1) incubation with 10 µmol/L mexiletine 
(48 hours) and recordings in the absence of mexiletine showed 46% increased Isus density. 
The Isus to peak current ratio remained the same as in untreated cells, implying that Isus is 
increased by mexiletine incubation as a direct consequence of rescuing of the trafficking. 2) 
Isus density recorded after incubation and in presence of 10 µmol/L mexiletine remained same 
as control (untreated cells) indicating that mexiletine treatment did not decrease Isus density 
because the rescue effect balanced out the block effect (Fig. 4D). 
 Immunostaining with anti-hNaV1.5 antibody confirmed that mexiletine incubation 
alleviates the trafficking impairment caused by F1473S. As shown in Fig. 5A and B, after 
mexiletine incubation the F1473S-NaV1.5 clusters were markedly reduced with a 
redistribution of the protein in the cytoplasm and in correspondence of the cell membrane 
(Fig. 5B, f vs. c). Analysis of the different cell fractions by Western blot showed that 
incubation with 10 µmol/L mexiletine increased the abundance of NaV-protein on the plasma 
membrane without affecting the total content of protein in whole cell homogenates (Fig. 5C). 
 
 
 
 
Figure 10. Simulated impact of F1473S mutation and mexiletine administration on AP. Panel A, 
membrane potential (upper) and INa (lower) obtained by pacing at 60 bpm the virtual cell in WT 
condition and when expressing heterozygous mutant channel. In the latter case the effect of mexiletine 
administration has been simulated by incorporating (or not) the effect of tonic block. B, F1473S 
prolongs AP over a broad range of pacing frequencies. The treatment with 10 µmol/L mexiletine 
induces a further AP prolongation, causing a capture failure at fast heart rate (inset shows the 
membrane potential obtained at 120 bpm). APD has been assessed at 90% of repolarization (APD90). 
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 Overall, our collaborators concluded that exposure to 10 µmol/L mexiletine did not 
decrease Isus, because the rescued trafficking of F1473S channel offset the blockade of Isus. On 
the contrary, peak current (and the resulting window current) was significantly increased by 
mexiletine as the rescuing effect overwhelmed the blocking effect on peak current.  
In silico evaluation of F1473S-NaV1.5 and mexiletine effects on AP 
We evaluated in silico the consequences of the biophysical properties of F1473S-NaV1.5. We 
tuned the Na channel Markov model (Clancy & Rudy, 1999; Clancy et al., 2002; Grandi et 
al., 2007) depicted in Fig. 6 to reproduces the experimentally observed mutant current 
behavior: we included the F1473S-induced effects on voltage-dependence of SSA and SSI 
(Fig. 7A) and time course of recovery from the inactivated state (Fig. 7B). We modified the 
model also to reproduce the ratio between sustained and peak current (Fig. 7C). In order to 
take into account the trafficking defect of mutant channels, GNa (set to 57.5 mS/μF for WT) 
was reduced by 80% (to 11.5 mS/μF) in F1473S (Fig. 7D). 
 The model faithfully reproduces the WT and F1473S current response to the positive 
voltage ramp protocol shown in Fig. 2E (Fig. 8A). Moreover, we simulated another voltage-
clamp protocol (characterized by a negative voltage ramp) to further study the non 
equilibrium Na channel gating properties (Clancy et al., 2003). By applying an AP-like 
voltage command, we obtained a F1473S-induced increase in both sustained current at the 
end of the plateau and in INa reactivation during the repolarization (Fig 8B). 
 We incorporated the INa model into a comprehensive model of human ventricular AP 
(ten Tusscher & Panfilov, 2006; Severi et al., 2009) in order to evaluate the effects of 
mutation and drug administration on the AP. Fig. 9 shows how AP prolongs when increasing 
the fraction of mutant Na channels. We assumed that, before treatment with mexiletine, in an 
heterozygote carrier of the F1473S mutation 50% WT proteins are entirely on the cell 
membrane whereas only 20% of the 50% defective trafficking F1473S-NaV1.5 are available. 
In this case, the mutation prolongs the AP by more than 200 ms when pacing the virtual cell at 
60 bpm, and this is due to the combination of the enlargement of window current and the 
increase in Isus (Fig. 10A). We obtained a F1473S-induced AP prolongation over a broad 
range of pacing frequencies (Fig. 10B). 
 After exposure to mexiletine, we assumed that the 50% of WT current is blocked by 
5% (in agreement with experimental findings) and that the F1473S current is increased by 
32% by concurrent blocking and rescuing effect of mexiletine. The model predicts the further 
prolongation of the AP (Fig. 10A), that leads to a capture failure at the fastest heart rate we 
simulated (Fig. 10B). 
 We then simulated the consequence of mexiletine exposure in absence of the drug (i.e. 
tonic block omitted), by considering further 10% increase in F1473S current (leading to a 
42% total increase), and found the maximal AP prolongation (Fig. 10A, dashed lines). 
DISCUSSION 
Mutations associated with LQT3 are characterized by a gain-of-function (George, 2005), 
suggesting that the pharmacological reduction of INa could attenuate the QT prolongation. 
Because its inception this hypothesis seemed to gather rapid confirmation in experimental 
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(Priori et al., 1996) as well as in clinical investigations (Schwartz et al., 1995; Benhorin et al., 
2000; Windle et al., 2001), and it supported the view that LQT3 patients would respond to 
such a "corrective" pharmacological treatment. Thus, the use of Na channel blockers has been 
widely supported and it was incorporated into guidelines for clinical practice to reduce the 
arrhythmic burden with an appropriately cautious class IIb recommendation (Zipes et al., 
2006). 
 As more SCN5A mutations were studied over the years, it has become progressively 
clear that they may combine different electrophysiological properties and induce complex 
phenotypes (Bezzina et al., 1999). Some mutations can bear, at the same time, gain-of-
function and loss-of-function properties. The Priori group reported a single amino acid 
deletion (lysine at position 1500) resulting in LQT, Brugada syndrome, and conduction 
disease in the same family (Grant et al., 2002). This observation was just one of several 
signals that raised concern that not all gain-of-function mutations should be considered equal 
and that the use of flecainide or mexiletine might be life saving for some but not for all LQT3 
patients (Makita et al., 2008). 
 In 2007, our collaborators attempted to establish whether the clinical response to 
mexiletine could be predicted on the basis of the biophysical properties detected with 
heterologous expression of SCN5A mutants. They suggested that the single most important 
factor that correlates with a positive response to therapy is represented by a left-ward 
displacement of SSI (Ruan et al., 2007). These findings highlighted the concept that knowing 
the in vitro consequences of mutants could guide clinical management. 
Heterogeneous biophysical properties of SCN5A mutations in LQT3 
Here, we characterize a novel mutant that seems to open another chapter, with therapeutic 
implications, in support of the view that the loss-of-function/gain-of-function paradigm may 
dangerously oversimplify the clinical approach to SCN5A mutation carriers (Priori, 2004) and 
that in vitro and in silico analysis of mutants might become a prerequisite to gene-specific 
therapy. Indeed, the evidence clearly indicates that in selected SCN5A mutations associated 
with a clinical phenotype suggestive of gain-of-function, the use of Na channel blockers may 
result in harmful rather than curative effects. 
 The present investigation was prompted by a clinical case in which a patient affected 
by an early onset LQT3 showed no clinical improvement with mexiletine and possibly 
presented a worsening of the substrate leading to in-hospital death. 
 Interestingly, another mutation at the same site, F1473C, was recently reported to be 
insensitive to mexiletine (Silver et al., 2009), and the carrier of the mutation continued to 
experience torsade de pointes after the drug, thus requiring implantable cardioverter 
defibrillator implantation and left stellate gangliectomy. The biophysical characterization of 
the F1473C reported by Bankston et al. (Bankston et al., 2007) is a completely different 
profile as compared with F1473S. F1473C causes a much smaller Isus (0.6% versus 5.39% in 
F1473S) and it does not reduce the peak current density. These observations highlight the fact 
that it is not possible to predict functional properties based on the location of a mutation and 
that in-depth functional studies are required. 
 Increased Isus (Bennett et al., 1995) and window current (Wang et al., 1996) are two 
known mechanisms for QT prolongation in LQT3. F1473S induces both to a considerable 
extent. Thus, two parallel biophysical abnormalities concur to generate the severe clinical 
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phenotype observed in the proband. It is worth noting that whereas mexiletine has a strong 
blocking effect on Isus it has only a mild blocking effect on peak current. In particular, we 
found that a clinically relevant concentration of mexiletine (10 µmol/L) blocked <3% of the 
peak current, whereas it blocked 28.8% of Isus. As a result, the improved trafficking induced 
by mexiletine was offset for the Isus but, because of the small peak INa blocking effect, the 
absolute amount of window current is greatly increased by this drug. When modeled in silico 
the effect of mexiletine resulted in a further AP prolongation, which is the likely culprit that 
tilted the balance toward the onset of life-threatening arrhythmias. 
Mexiletine and the unexplained mechanisms for rescuing trafficking of 
NaV1.5 mutants 
Mexiletine trafficking-rescuing activity has been demonstrated for several NaV1.5 mutants 
(Valdivia et al., 2002; Valdivia et al., 2004; Tan et al., 2006; Pfahnl et al., 2007) but the 
underlying mechanisms remain elusive. It has been suggested that drugs may act as "chemical 
chaperones" to promote protein folding and thereby facilitating the exit of mutant ion channel 
from the ER (Herfst et al., 2004; Gong et al., 2006). In the case of F1473S, we observed only 
a small fraction of the mutant protein in the ER, thus suggesting that this mechanism is 
unlikely to play a major role in improving membrane localization. Ankyrin-G dependent 
SCN5A trafficking (Lowe et al., 2008) is another potential mechanism. The Priori group 
previously demonstrated that a human SCN5A mutation (E1053K) identified in a Brugada 
patient impairs ankyrin-G binding leading to a trafficking defect (Mohler et al., 2004). E1053 
is localized in the predicted 9-aa ankyrin binding motif in the DII-III intracellular loop of 
NaV1.5 (VPIAVX[E]SD), but we cannot exclude that F1473S, which is in the DIII-DIV 
intracellular loop, similarly causes an impaired interaction with ankyrin-G. 
 Another poorly understood aspect of the efficacy of mexiletine in modulating protein 
localization is related to the concentration at which the effect is observed. Most of the studies 
used high concentrations of mexiletine, suggesting that a high dosage might be required to 
improve membrane targeting. Ackerman and colleagues were the first to report rescuing of 
G1743R (Valdivia et al., 2004) using clinical concentrations of mexiletine (10 µmol/L), 
pointing to the evidence that the efficacy is independent of the dosage; experimental data 
(obtained with 10 µmol/L mexiletine) here provided support this view. It was suggested that 
only mutations located in extracellular loop region of the SCN5A could be rescued by Na 
channel blockers: the mutant studied here is located intracellularly; thus, it supports the idea 
that the position of the mutation is unlikely to be the key trafficking controlling factor of the 
NaV1.5 polypeptide. 
The need to revisit recommendations for the use of Na channel blockers in 
LQT3 
Improvement of trafficking in defective SCN5A mutations has been considered as a 
therapeutic strategy that should be applied irrespective of the biophysical profile of mutants; 
our study provides in vitro and in silico proof of concept that this assumption may be 
incorrect and potentially harmful. In an interesting editorial, Bezzina and Tan hypothesized 
that rescuing mutant channels with abnormal gating behavior could pose a proarrhythmic 
threat (Bezzina & Tan, 2002). We now provide the first direct evidence of this hypothesis. 
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 Our data establish a link between experimental data and clinical observations raising a 
warning flag to the "blanket indication" to use mexiletine in LQT3 patients. The improvement 
of trafficking of a gain-of-function mutant by mexiletine may be arrhythmogenic despite the 
channel blocking effect that would tend to counteract such a gain-of-function phenotype. The 
simulation shows that improvement of trafficking increases window current that is only 
minimally inhibited by mexiletine and thus contributes to APD prolongation. 
 It took the unfavorable outcome of the severely ill child affected by LQT3 to 
demonstrate that the loss-of-function/gain-of-function paradigm to classify SCN5A mutants is 
inadequate and that use of Na channel blockers in LQT3 patients may be a double-edged 
sword posing a hazard to patient carriers of a SCN5A mutation with undefined 
electrophysiological properties. 
Study limitations 
We acknowledge the presence of limitations in this study. In vitro experiments in 
heterologous systems are widely used but they do not get rid of factors that may importantly 
modulate the effect of a mutation in the "real world," such as temperature (Keller et al., 2005) 
or genetic background (influence of modulatory polymorphisms) (Poelzing et al., 2006; Tan 
et al., 2006). Furthermore, in vitro experiments do not consider the important contribution to 
arrhythmogenesis of the signaling pathways, receptors, and autonomic modulation. 
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CHAPTER 2 
Theoretical Study of L-type Ca Current 
Inactivation Kinetics during Action Potential 
Repolarization and Early Afterdepolarizations 
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Abstract 
Sarcoplasmic reticulum (SR) Ca release mediates excitation-contraction coupling (ECC) in 
cardiac myocytes. It is triggered upon membrane depolarization by entry of Ca via L-type Ca 
channels (LTCCs), which undergo both voltage- and Ca-dependent inactivation (VDI and 
CDI). To differentiate VDI and CDI, several studies have considered the inactivation of Ba 
current through LTCC (IBa) as a measure of VDI. However, there is evidence that Ba can 
weakly mimic Ca, such that IBa inactivation is still a mixture of CDI and VDI. To avoid this 
complication, some have used the monovalent cation current through LTCC (INS, which can 
be measured when divalent cation concentrations are very low). INS inactivation rate does not 
depend on current amplitude, and hence may reflect purely VDI. However, based on analysis 
of existent and new data, we find that INS can inactivate more rapidly and completely than IBa, 
especially at physiological temperature. Thus, data about IBa inactivation have been 
considered in the development of improved model of L-type Ca current within the framework 
of the Shannon-Bers rabbit ventricular action potential (AP) model, in which the formulation 
of SR Ca release was modified to reproduce high ECC gain at negative membrane voltages. 
We extended an existing LTCC Markov model in order to reflect more faithfully 
contributions of CDI and VDI to total inactivation, by taking into account a small contribution 
of ion-dependent inactivation (in addition to pure VDI) when Ba is the charge carrier. Under 
physiological conditions (during an AP) LTCC inactivates predominantly via CDI, which is 
controlled mostly by SR Ca release during the initial AP phase, but by Ca through LTCCs for 
the remaining part. Simulations of decreased CDI or K channel block predicted the 
occurrence of early and delayed afterdepolarizations. Our model accurately describes ECC 
and allows dissection of the relative contributions of different Ca sources to total CDI, and the 
relative roles of CDI and VDI, during normal and abnormal repolarization. 
INTRODUCTION 
The L-type Ca current (ICa) critically regulates excitation-contraction coupling (ECC) in 
cardiomyocytes (Bers, 2001) by triggering sarcoplasmic reticulum (SR) Ca release, and 
modulating action potential (AP) shape and duration (APD), i.e. maintaining the long AP 
plateau. Moreover, ICa plays an important role in the development of cardiac arrhythmias. 
Indeed, at the single myocyte level it has been implicated in the development of early 
afterdepolarizations (EADs) in classical studies by January and colleagues (January et al., 
1988; January & Riddle, 1989), who presented evidence linking EADs in Purkinje fibers with 
reactivation of ICa during the AP plateau. Several modeling studies have highlighted the 
importance of ICa in EAD formation in different animal species and cardiac cell types (Zeng 
& Rudy, 1995; Tanskanen et al., 2005; Corrias et al., 2011). Under a number of patho-
physiological conditions that tend to prolong APD (as in hypertrophic and failing hearts) ICa 
may become arrhythmogenic (Benitah et al., 2010), even in the absence of disease-induced 
alteration of the current itself, as the longer AP plateau provides more time for Ca channel 
reactivation and facilitates the occurrence of EADs. 
 ICa is conducted by CaV1.2 channels consisting of a pore-forming α1C subunit, with 
four homologous domains of six transmembrane segments, in association with β and α2-δ 
subunits (Catterall, 2000). The C terminal domain of the α1C subunit contains several 
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regulatory sites, such as a protein kinase A phosphorylation site, an EF-hand region and an IQ 
motif at which calmodulin (CaM) can bind. ICa is rapidly activated by membrane 
depolarization, whereas inactivation of L-type Ca channels (LTCC) is regulated by both Ca- 
and voltage-dependent inactivation (CDI and VDI) (Lee et al., 1985). CDI is due to binding 
of Ca to CaM (Peterson et al., 1999; Zuhlke et al., 1999), which causes a channel 
conformational change that prevents the EF-hand in the C-terminus from interacting with the 
cytosolic I-II linker, which then occludes the channel pore, thus accelerating inactivation 
(Cens et al., 2006). CDI is an important feedback mechanism that limits the amount of Ca 
entry during each Ca transient, regulates sarcoplasmic reticulum (SR) Ca load and modulates 
APD (Bers, 2001). Indeed, prevention of CDI by expression of a mutant Ca-insensitive CaM 
in adult cardiomyocytes induces a dramatic (4- to 5-fold) prolongation of the cardiac AP 
(Alseikhan et al., 2002). Computational analysis also identified CDI as the key player in 
      
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Ion current inactivation through 
the LTCC. A) Normalized Ca, Ba and Na 
currents (ICa, IBa and INS) measured at 0 mV 
(except INS at -30 mV to obtain comparable 
activation state). ICa was recorded under 
conditions where normal SR Ca release and Ca 
transients were allowed to occur (perforated 
patch) or prevented (ruptured patch with cells 
dialyzed with 10 mM EGTA). IBa was also 
recorded in absence of Ca release and transient. 
INS was measured in divalent-free conditions 
(10 mM EDTA inside and out). B) Ratio 
between pedestal and peak current, in response 
to a 1000 ms-depolarizing step to 0 mV, is 
plotted against current amplitude of IBa and INS. 
The lines represent linear regressions. Data are 
from (Brunet et al., 2009). C) INS and ICa 
availability through Ca channels (at -10 mV) 
after 500 ms pulses to the indicated Em in 
guinea pig ventricular myocytes (redrawn from 
(Hadley & Hume, 1987)). 
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shortening the AP when external [Ca] is increased (Grandi et al., 2009). The physiological 
significance of VDI is illustrated by the dramatic consequences of Timothy syndrome 
(Splawski et al., 2004; Splawski et al., 2005; Brunet et al., 2009), which impairs VDI and 
causes severe ventricular arrhythmias (and dysfunction in other tissues, e.g., brain). 
 ICa inactivates with a biexponential time course when Ca is the charge carrier, and it 
has been widely assumed that the initial fast decay represents CDI, and the slower phase 
reflects VDI. During ECC, with normal SR Ca release and Ca transient (CaT), local [Ca]i near 
the LTCC is elevated and inactivation is rapid (Fig. 1A top ICa trace, t1/2=17 ms). When Ca 
transients are abolished (e.g., by ryanodine or very strong [Ca]i buffering), ICa inactivation is 
slower (Fig. 1A, t1/2=37 ms) and reflects a small rise in local [Ca]i near the mouths of LTCCs 
due to Ca entering via the channels themselves. In addition to Ca, LTCCs allow permeation 
by other ions including Na, K, Sr, Cs, Ba, depending on ionic conditions, but inactivation is 
slower than with Ca and monoexponential when Ba, Sr, or Na are the charge carrier. 
 To differentiate VDI from CDI, several experimental and theoretical studies have used 
inactivation of Ba current via LTCC (IBa) as a measure of VDI (Lee et al., 1985; Peterson et 
al., 2000; Cens et al., 2006; Mahajan et al., 2008b; Thiel et al., 2008). However, there is 
evidence that Ba can weakly mimic Ca (Ferreira et al., 1997), such that IBa inactivation is still 
a mixture of CDI and VDI, and IBa inactivation depends on current amplitude (Fig. 1A, 
t1/2=161 ms, and Fig. 1B). To avoid this complication, some have used the monovalent (non 
specific) cation current through LTCC (INS), which can be measured only when divalent 
cation concentrations are very low (Hadley & Hume, 1987; Hryshko & Bers, 1992; Yuan et 
al., 1996; Sun et al., 2000; Brunet et al., 2009). That is, extracellular Ca and Mg block INS 
(ki~1 and 50 µM respectively). Notably, INS inactivation rate does not depend on current 
amplitude (Fig. 1B, grey line) and hence could reflect purely VDI (Brunet et al., 2009). 
Inward INS has been reported to inactivate very slowly (Fig. 1A, t1/2>500 ms at a membrane 
potential (Em) of -30 mV). Even at more positive Em, where inactivation is faster, it is still 
incomplete (Fig. 1C). Note that extracellular divalent cations screen external membrane 
surface charge, shifting the membrane field and channel gating to more positive Em. Thus, the 
activation state of INS at -30 mV is comparable to that of ICa or IBa at ~0 mV in Fig. 1A 
(Hadley & Hume, 1987; Linz & Meyer, 1998; Bers, 2001). 
 In the present study, we sought to determine whether INS or IBa is appropriate for the 
development of a ICa model in which the contributions of CDI and VDI to total inactivation 
are faithfully reproduced. New and existing data suggest that, at physiological temperature, 
INS inactivation is faster and more complete than IBa inactivation. Since IBa exhibits a weak 
ion-dependent inactivation (IDI), neither IBa nor INS are accurate measures of VDI for ICa, 
although IBa VDI is largely like ICa VDI. Accordingly, we improved a theoretical model of 
LTCC kinetics that accounts for the weak Ba-dependent inactivation, integrated into a rabbit 
ventricular AP model, in which the formulation of SR Ca release was modified to reproduce 
the experimentally measured Em-dependence of ECC gain. With this updated myocyte model, 
which was validated against a broad range of experimental data, we showed that CDI, 
dominated by SR Ca release at the beginning of the AP and by Ca via LTCCs for the 
remaining part, outweighs VDI in physiological conditions. Impairment of CDI is predicted to 
cause to AP prolongation and triggered activity depending on its degree of reduction. New 
insights into EAD formation were obtained using the model, and ICa kinetics was analyzed 
during these abnormal APs. 
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METHODS 
INS measurements 
Ventricular myocytes were dissociated enzymatically from hearts of adult male New Zealand 
White rabbits using a standard Langendorff perfusion procedure, as has been described 
previously (Bassani et al., 1994). Isolated cells were allowed to adhere to laminin-treated 
coverslips and were used acutely. Monovalent current via LTCCs was recorded in whole cell 
ruptured-patch mode as described previously (Yuan et al., 1996). Cells were held at -65 mV 
and stimulated with infrequent (<0.1 Hz) depolarizing steps. The bathing solution contained 
 
 
 
 
Figure 2. SR Ca release and LTCC models. A) Schematic diagram of dyadic cleft fluxes of the ventricular 
myocyte AP model (Shannon et al., 2004). Voltage-dependence of SR Ca release was introduced as in inset. 
B) Structure of the LTCC Markov model (Mahajan et al., 2008b) as modified for this study. 
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(mM): 10 NaCl, 6 CsCl, 5 EDTA, 120 TEA-Cl, 10 glucose and 10 H-Hepes, adjusted to pH 
7.4 with TEA-OH. The pipette solution contained (mM): 3 NaCl, 120 CsCl, 10 EGTA, 5 
MgATP, 0.3 GTP, buffered to pH 7.2 with 20 mM H-Hepes and CsOH. Importantly, in 
recording INS, EDTA was used to ensure chelation of both Ca and Mg, to prevent Mg from 
blocking the current (ki~50 µM) (Matsuda, 1986; Hryshko & Bers, 1992). A measured liquid 
junction potential of 5 mV was corrected during analysis. Experiments were conducted at 
room temperature (22°C); a few recordings were obtained at 25°C and 35°C as specified in 
the results. Current decay was fitted with a monoexponential time constant (τ), with a steady-
state plateau at the end of the voltage step. Use of biexponential functions did not improve the 
fitting. 
Modeling Ba-dependent inactivation 
A preliminary analysis was done in order to estimate a appropriate reduction factor to model 
the weaker affinity of Ba vs. Ca for CaM. We used a minimal Markov model for ICa (Fig. 2B) 
that was developed previously by the Weiss group (Mahajan et al., 2008b), based on ICa and 
IBa measurements in rabbit ventricular myocytes at physiological temperature. Inactivation of 
ICa is described as occurring via VDI and CDI (or IDI) pathways. In the original formulation 
IBa inactivation was considered to define the VDI pathway only. Here, we used both their 5-
state model of IBa and an alternative 7-state IBa model, which uses the IDI pathway with 
parameters tuned to mimic a reduced affinity of Ba vs. Ca for CaM (i.e. [Ba] was reduced by a 
factor 1, 3, 10, 20, 30, 50 100 in the expression of the ion-dependent transition rates). We 
scaled the permeability (and single channel conductance) of LTCCs for Ba in agreement with 
experimental results (Bers, 2001). Models of IBa were inserted into the AP a model developed 
by the Weiss group (Mahajan et al., 2008b). Model differential equations were implemented 
in Matlab (Mathworks, Natick, MA, USA) and solved numerically using a variable order 
solver (ode15s). The digital cell was stimulated with voltage steps replicating the 
experimental protocols. 
ICa and SR Ca release models development 
The Shannon-Bers model of a rabbit ventricular myocyte (Shannon et al., 2004) provided the 
computational framework for this study, where the only changes are on the ryanodine receptor 
(RyR) and ICa properties (Fig. 2).  
 A voltage-dependent modulation of RyR opening was included in the formulation of 
SR Ca release (Fig. 1A, inset). Specifically, SR Ca release flux was obtained by multiplying 
RyR open probability by the SR to cleft Ca concentration gradient and maximal release flux 
(as usual), and a Em-dependent factor described by the following equation: 
)(1
)( VEkm me
aEf  , 
where a=1.5, k=0.065 mV-1 and V=30 mV. This reduces RyR Ca flux at positive Em (Fig. 2A, 
inset). This is not meant to imply that RyR has intrinsic Em-dependence, but this 
phenomenological adjustment allows our common pool model to recapitulate experiments 
showing lower efficacy of macroscopic ICa to trigger SR Ca release at more positive Em, as 
depicted in Fig. 3A (Beuckelmann & Wier, 1988; Bers, 2001; Altamirano & Bers, 2007). At 
more negative Em, fewer LTCCs open, but the unitary flux is larger (due to larger driving 
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force), causing more efficient Ca-induced Ca release and higher ECC gain (measured as the 
ratio of CaT amplitude to peak ICa in Fig. 3B). Gain at negative Em is high, in part, because a 
single Ca channel opening may trigger junctional release but as more channels are recruited 
(e.g., approaching 0 mV) there is more trigger redundancy of LTCC opening per release unit, 
and a consequently smaller denominator in the gain equation (Altamirano & Bers, 2007). At 
increasingly positive Em (where unitary currents are small), multiple openings are needed to 
assure RyR opening, which results in lower gain. This circumvents the need here for local 
stochastic interactions between LTCCs and RyRs in thousands of Ca release units (Restrepo 
et al., 2008; Lee et al., 2011). The modified formulation predicted higher CaT amplitude for a 
given ICa at negative Em and lower amplitude at positive Em (Fig. 3C) and the expected 
decreasing ECC gain with stronger depolarization (Fig. 3D). 
 The 7-state ICa model depicted in Fig. 2B (Mahajan et al., 2008b) was incorporated 
into the ECC model and the total current was computed as follows: 
 
i c
ciCaCa II , , 
 
 
 
Figure 3. ECC gain. Experimental (guinea pig ventricular myocytes (Beuckelmann & Wier, 1988; Bers, 
2001)) and simulated dependence of CaT amplitude on ICa (A and C) and ECC gain (ratio of CaT amplitude 
to peak ICa) on Em (B and D). Simulated results were obtained in response to voltage steps from -80 mV to 
various Em, and are shown with (solid black lines) and without (dashed grey) Em-dependent modulation of 
SR Ca release (Fig. 2A, inset). Initial conditions were set as steady-state values obtained by stimulating the 
cell at 1.5 Hz with 300 ms voltage steps to 0 mV (from a resting potential of -80 mV). 
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where c are the compartments (cleft and sub-sarcolemma) and i are Ca (or alternatively Ba), 
Na and K ions. For each c and i: 
cOciCacxciCa PiFI   ,, , 
where Fx-c represents the fraction of the LTCCs in c (90% in cleft, 10% in sub-sarcolemma), 
PO-c is the LTCC open probability calculated solving the system of differential equations 
describing the rate of changes of state occupancies in Fig. 2B, and iCa-i,c is the current across 
the membrane carried by ion i calculated with the Goldman-Hodgkin-Katz flux equation: 
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where Pi is the permeability of the membrane for ion i, zi is the valence of ion i, F is the 
Faraday constant, R is the gas constant, T is the absolute temperature, [i]c is the concentration 
of ion i in c, and [i]o is the extracellular concentration of ion i. Markov model parameters 
were constrained to match experimental data obtained under various Ba/Ca homeostasis 
conditions. IBa was simulated by replacing Ca with Ba in the extracellular solution 
composition and Ba entering the cell via LTCC was assumed to affect local [Ba] (i.e. sub-
sarcolemmal and cleft [Ba]) without altering bulk [Ba] (Fig. 2A) or triggering SR Ca release 
(Ferreira et al., 1997). With Ba as the charge carrier, Mahajan and colleagues modeled 
inactivation to occur only via the VDI pathway. That is, during IBa the two upper states in Fig. 
2B (CDI) are never visited, and the model is effectively reduced to the lower 5 states. In 
contrast, we obtained our IBa model parameters by fitting the voltage- and Ba-dependence of 
VDI and CDI rate constants to the measured IBa with 8-fold weaker apparent affinity of Ba vs. 
Ca for CaM (this reduction value has been adapted from that one estimated in the preliminary 
analysis). These parameters were also constrained to fit ICa data (with Ca as the charge carrier) 
with normal CaT, or without SR Ca release and with the Ca buffers EGTA or BAPTA. We 
made simplifying assumptions that, in the absence of release and presence of Ca buffers, Ca 
entering the cell via LTCC affects sub-sarcolemmal and cleft [Ca] without altering bulk [Ca] 
(for EGTA), or [Ca] is clamped at diastolic values in all compartments (for BAPTA). LTCC 
permeability values for Ba and Ca were set to reproduce the values of peak current 
experimentally measured (Mahajan et al., 2008b) at physiological temperature. Model rate 
parameters were chosen to reproduce kinetics at 37°C, and a Q10 of 2 (Faber et al., 2007) was 
used to scale the duration of voltage pulses of experimental data obtained at room 
temperature. Moreover, the scaling parameter γi-Ca in the Goldman-Hodgkin-Katz equation 
was reduced to avoid reverse flux through LTCCs at elevated cleft [Ca]. The full list of model 
equations and parameters can be found in the Tables 1 and 2 (where Em is in V, [i]c, charge 
carrier (Ca or Ba) concentration in the compartment c, is in mM and aff is 1 with ICa and 1/8 
with IBa). To simulate reduced VDI, parameters aRv1 and aRv2 were reduced by 70%, while 
CaM1234 expression was simulated by assuming that the overexpressed CaM1234 displaced the 
wild type (WT) CaM in a fraction α of LTCCs in the cell, such that this population of 
channels exhibited VDI but not CDI (i.e. ICa,VDI with the reduced 5-state model), as done 
previously by the Weiss group (Mahajan et al., 2008a). Thus, total ICa,CaM1234 is given by: 
VDICaCaMCa II ,Ca, )I-1(1234   . 
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 Ionic concentrations were set to the following values (in mM): [Cl]i 5, [Cl]o 146, [K]i 
140, [K]o 5.4, [Na]o 135, [Ca]o 2 (or [Ba]o 1.8), as in (Mahajan et al., 2008a). During EAD-
like AP-clamp, the following values were changed: [Cl]i 15, [Cl]o 150, [K]i 135, [Na]o 140, 
[Ca]o 1.8, as in (Shannon et al., 2004). The reduced Cl driving force diminished background 
Cl currents, thus reducing the repolarization reserve. Model equations were implemented in 
Simulink (Mathworks, Natick, MA, USA) and solved numerically with a stiff variable order 
 Table 1. LTCC model transition rate expressions. 
 
Transition rate expressions 
k1 = k1o fcp 
k2 = k2o 
k3 = PT/sp1 
k5 = (1-PS)/TCa 
k6 = PS fcp/ TCa 
s1 = s1o fcp 
α = R2/T2 
β = (1-R2)/T2 
r1 = R1/T1 
r2 = (1-R1)/T1 
k6' = Rv2/Tv2 
k5' = (1-Rv2)/Tv2 
k1' = Rv1/Tv1 
k2' = (1-Rv1)/Tv1 
k3' = 1/(Trev2 (1+Frev2)) 
k4' = k3' Frev2 
s1' = 1/(Trev1 (1+Frev1)) 
s2' = s1' Frev1 
k4 = k3 (k5/k6) (k1/k2) (α/β) 
s2 = s1 (k2/k1) (r1/r2) 
where 
fcp = 1/(1+(cpt/aff/[i]c)3) 
TCa = PQ ((R-tca) PR+tca) 
tca = (sp9/(1+([i]c aff/cat)4))+sp10 
R = sp7+sp8 exp(Em/sp6) 
PT = 1-(1/(1+exp(-(Em+sp2)/sp3))) 
PQ = 1+sp0/(1+exp(-(Em+sp2)/sp4)) 
PR = 1-(1/(1+exp(-(Em+sp2)/sp4))) 
PS = 1/(1+exp(-(Em+sp2)/sp5)) 
R2 = aR2/(1+exp(-(Em+sR2) pR2)) 
T2 = aT2/(1+exp(-(Em+sT2) pT2)) 
R1 = aR1/(1+exp(-(Em+sR1) pR1)) 
T1 = aT1/(1+exp(-(Em+sT1) pT1)) 
Rv2 = aRv2/(1+exp(-(Em+sRv2) pRv2)) 
Tv2 = aTv2/(1+exp(-(Em+sTv2) pTv2)) 
Rv1 = aRv1/(1+exp(-(Em+sRv1) pRv1)) 
Tv1 = aTv1/(1+exp(-(Em+sTv1) pTv1)) 
Trev2 = aTrev2/(1+exp(-(Em-sTrev2) pTrev2)) 
Frev2 = (1-Rv2) R2 Rv1/(Rv2 (1-R2) (1-Rv1)) 
Trev1 = aTrev1/(1+exp(-(Em-sTrev1) pTrev1)) 
Frev1 = (1-Rv1) R1/(Rv1 (1-R1)) 
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solver (ode15s) based on the numerical differentiation formulas (NDFs) with an adaptive time 
step ranging from 1 ms to 1 ps. The digital cell was stimulated in voltage- or AP-clamp to 
replicate experimental protocols. Initial conditions were set as steady-state values obtained by 
stimulating the cell (in various Ba and Ca homeostasis conditions) at 1 Hz with 300 ms 
voltage steps to 0 mV (from a resting potential of -80 mV). AP-clamp simulations were 
performed with a command AP simulated by pacing the cell in current-clamp (15 A/F current 
stimulus lasting 3 ms) at 0.33 Hz to steady-state with normal CaT. APs showing EADs were 
also used as a command voltage. A gapped double-pulse (GD-P) protocol was implemented in 
which the AP-clamp was interrupted at defined potentials. Em was then stepped back to -40 
mV for 2 ms, followed by a 200 ms rectangular test pulse to 5 mV. The fraction of available 
channels at each time during the AP was calculated by normalizing peak ICa evoked by the 
corresponding test pulse to the peak ICa elicited by a rectangular clamp step from -80 to 5 mV 
(when the channels are fully available). Inactivation (i.e. 1-availability) was plotted against 
the time elapsed between AP upstroke and interruption. 
RESULTS 
Experimental analysis of INS and IBa inactivation kinetics 
Typical recordings of INS (with Na and Cs as charge carriers) are shown in Fig. 4A, elicited by 
depolarizing pulses described in inset. With increasing depolarization, the net current changes 
from inward to outward, due to reduction in the driving force for Na and an increased driving 
force for Cs (INS reversal potential is about -4.5 mV). We characterized INS kinetics by 
considering the time course of current decay throughout the duration of depolarization. Time 
constants (τs) of inactivation are reported in Fig. 4B for each depolarization Em. Current decay 
is slower at Em<-10 mV, and is hastened as the voltage steps are more depolarized (and the 
 
 Table 2. LTCC model parameters. 
 
Parameter Value Unit 
F 96845 C/mol
R 8.314 J/mol/K
T 310 K
zCa 2 -
zBa 2 -
zK 1 -
zNa 1 -
 i-Ca 0.0341 -
 o-Ca 0.341 -
 i-Ba 0.0341 -
 o-Ba 0.341 -
 i-K 0.75 -
 o-K 0.75 -
 i-Na 0.75 -
 o-Na 0.75 -
PCa 24.3e-6 m/s
... 
Computational Modeling of Cardiac Excitation-Contraction Coupling 
in Physiological and Pathological Conditions 
Stefano Morotti 47 
Parameter Value Unit 
PBa 23.22321e-6 m/s
PK 12.15e-9 m/s
PNa 0.675e-9 m/s
Fx-cleft 0.9 -
Fx-sl 0.1 -
cpt 3.75e-3 mM
cat 7.617e-3 mM
s1o 18.2688 s-1
k1o 24.168 s-1
k2o 0.103615 s-1
sp0 1.5 -
sp1 3e-3 s
sp2 40e-3 V
sp3 3e-3 V
sp4 4e-3 V
sp5 11.32e-3 V
sp6 15.6e-3 V
sp7 10e-3 s
sp8 4954e-3 s
sp9 78.0329e-3 s
sp10 0.1e-3 s
aR2 1 -
sR2 0.002 V
pR2 145 V-1
aT2 0.001 s-1
sT2 1 V
pT2 100 V-1
aR1 0.09091 -
sR1 1 V
pR1 100 V-1
aT1 0.00030303 s-1
sT1 1 V
pT1 100 V-1
aRv2 0.9 -
sRv2 0.029 V
pRv2 135 V-1
aTv2 0.5 s-1
sTv2 0.025 V
pTv2 50 V-1
aRv1 0.85 -
sRv1 0.18 V
pRv1 90 V-1
aTv1 0.27 s-1
sTv1 0.18 V
pTv1 100 V-1
aTrev1 0.20512 s-1
sTrev1 0.065 V
pTrev1 100 V-1
aTrev2 7e5 s-1
sTrev2 0.06 V
pTrev2 130 V-1
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current becomes outward). Nevertheless, INS inactivation τs measured in rabbit ventricular 
myocytes at room temperature are relatively fast (especially compared to the INS trace in Fig. 
1A). INS inactivation was assessed in the same cell at two different temperatures (25 and 
35°C, Fig. 4 C vs. D). Availability curves were recorded using various durations of the 
inactivating pre-pulses, and τ of inactivation was estimated as described in (Findlay, 2002b). 
At physiological temperature INS inactivated more completely and rapidly than at room 
temperature. From these measurements, we calculated an average Q10 of ~1.85 for INS 
inactivation kinetics over the full range of Em (although Q10 was larger at more negative Em: 
~2.3 at -20 mV). We compared our data (corrected at 37°C, Fig. 5A, diamonds) with 
previously published inactivation τs and found concordance with several previous studies of 
INS inactivation. 
 INS inactivation τs values were averaged (broken curve in Fig. 5A) and plotted vs. Em 
as inactivation rate constants (k=τ-1) in Fig. 5B, along with rate constants of inactivation of IBa 
and ICa (biexponential for ICa from (Mahajan et al., 2008b)). ICa inactivation is faster when SR 
Ca release is present (top curve). Notably, INS inactivation was much faster than IBa 
inactivation, which was comparable to the slow component of ICa inactivation. INS inactivation 
 
 
 
Figure 4. Kinetics of INS inactivation. A) Representative recordings of membrane currents in rabbit 
ventricular myocytes elicited by 200-ms steps (inset) from -65 mV to the indicated Em. B) τ of INS decay. C 
and D) INS availability recorded at 25°C and 35°C following pre-pulse steps of 362, 148, 59, 26, 6.5, 3.5, 
1.75 ms duration. Data from C and D have been transposed onto a time scale (availability against pre-pulse 
interval) and τs were calculated as in (Findlay, 2002c). 
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becomes faster with increasing depolarization consistent with VDI, and gets faster when the 
current is outward. Thus, INS inactivates more rapidly and completely than IBa at 35-37°C 
(even if one accounts for surface charge effects). Thus, these cannot both reflect the same 
VDI process. Moreover if INS exhibits pure VDI, then the rate of IBa inactivation (which may 
include some weak CDI) would have to be faster than INS inactivation (i.e. kVDI+f(kCDI)). 
So INS inactivation is too fast to reflect the VDI that occurs during IBa. On the other hand, IBa 
is not purely VDI either, because the rate of inactivation has a bell-shaped Em-dependence 
(Fig. 5B, inset, and Fig. 6, circles, (Mahajan et al., 2008b)) and increases with larger peak Ba 
current amplitude, as shown in Fig. 1B (Brunet et al., 2009). 
 We suggest that INS inactivation is VDI, but that it is fundamentally (mechanistically) 
different from VDI that occurs during IBa or ICa, and may therefore not be useful to 
characterize the VDI component of ICa. Further, IBa inactivation includes a moderate 
component of CDI (where Ba substitutes for Ca) and also VDI that is the same as the VDI 
component of ICa. Indeed, with strong fast intracellular Ca buffering, ICa inactivation is 
reduced (Katzka & Morad, 1989; Linz & Meyer, 1998) and approaches that seen for IBa. 
Quantitative assessment of Ba-dependent inactivation 
We sought to determine whether and how experimental IBa inactivation (traditionally used in 
VDI experiments and models) could be recapitulated by extending a previously published 
model of CDI (Mahajan et al., 2008b) to account for Ba-dependent inactivation. To mimic a 
reduced affinity of Ba (vs. Ca) in CDI, the parameters describing the Ca-dependent transitions 
(Fig. 2B) were modified to make it 3-100 times less sensitive to [Ba] (vs. [Ca]). In Fig. 6A 
normalized IBa simulated in response to a voltage step to 0 mV are shown. As the apparent 
affinity of Ba for CaM increases (approaching that of Ca), IBa exhibits faster inactivation (Fig. 
 
 
 
Figure 5. INS, IBa and ICa inactivation rates at physiological temperature. A) Voltage-dependence of the 
decay time of INS. Data from (Mitarai et al., 2000) were collected at physiological temperature. All the other 
experimental data were obtained at room temperature and here rescaled at 37°C (Q10=1.85). The dashed line 
is obtained by interpolation of the averaged τ. B) Rates of the fast and slow components of a double 
exponential fit of ICa decay vs. Em recorded by (Mahajan et al., 2008b) with and without CaT. Rates of IBa 
(shown also in the inset) and INS (dashed lines) inactivation are obtained from monoexponential fits of 
current decay. 
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5B). The τ of IBa decay (at 0 mV) is ~125 ms when the current inactivation is modeled as Ba-
independent (e.g., only including VDI). When Ba affinity is much smaller than that of Ca (20-
100 times), the predicted Ba-dependent inactivation is negligible, still indistinguishable from 
only the 5-state VDI model. Only when the relative kCa/kBa affinity falls to 10 or below does 
Ba-dependent inactivation become appreciable. Fig. 6B also shows the maximal probability of 
occupancy of the two Ba-dependent inactivation states (filled and open squares). The channel 
never visits these states by design when only VDI is implemented, and state occupancies are 
infrequent when Ba affinity for CaM is low. Ion-dependent inactivated states are more likely 
to be occupied when Ba affinity increases (e.g., when kCa/kBa is equal to 10, τ is reduced by 
about one fifth). When Ba affinity equals that of Ca, τ of IBa inactivation is the same as ICa 
(without SR Ca release), and the probabilities of occupancy of Iion1 and Iion2 are maximal. 
When Ba is used instead of Ca in experiments, the normal myocyte Ca extrusion pathways do 
not remove Ba well, so that intracellular Ba would accumulate over several beats. Simulations 
show that the τ of IBa decay decreases as intracellular [Ba] increases (Fig. 6C), whereas it is 
 
 
 
Figure 6. Kinetics of simulated IBa inactivation. A) Normalized IBa traces obtained when applying a 
voltage step to 0 mV (from a holding potential of -80 mV) and kCa/kBa is equal to 100, 50, 30, 20, 10, 3, 1 
(VDI+f(CDI)). IBa was also simulated as independent of Ba flux (VDI only, dashed line). B) Left ordinate: τ 
of IBa decay decreases as the simulated Ba affinity for CaM is increased (i.e. kCa/kBa decreased). Right 
ordinate: ion-dependent state occupancy during IBa decay (in response to a voltage step to 0 mV) is enhanced 
with increasing affinity of Ba for CaM (i.e. decreasing kCa/kBa). C) Effect of intracellular Ba accumulation on 
current inactivation. Normalized IBa traces obtained in response to a voltage step to 0 mV are shown in 
correspondence of various levels of [Ba]i (from 1 nM to 150 µM). D) τ of IBa decay at the indicated Em when 
IBa inactivation is simulated as independent of Ba flux (VDI only, dashed line) and when Ba affinity for 
CaM is varied ((VDI+f(CDI)), kCa/kBa from 100 to 1). Experimental data are from (Mahajan et al., 2008b). 
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unchanged when using the 5-state VDI only IBa model (not shown). In Fig. 6D the effect of 
Ba-dependent inactivation is shown over a wide range of voltages. Note that the τ for ICa (or 
IBa at kCa/kBa=1) reflects the strong CDI seen for ICa, whereas the curve for kCa/kBa=10 
approaches the shape seen for IBa measurements. While the model is an imperfect match to the 
data, this simple version provides a useful framework for separating VDI and CDI for ICa and 
IBa. 
 
 
 
 
 
Figure 7. ICa model identification. Experimental (top) and simulated (bottom) I-V relationships and quasi-
SSI for IBa (A, D), ICa without SR Ca release (B, E), and ICa with CaT (C, F). I-V curves were obtained by 
stimulating the cell with voltage steps from a resting potential of -80 mV to various test potentials. Quasi-
SSI curves were obtained by measuring the available current after inactivation pre-pulses of various 
(indicated) durations. Results for simulated IBa with a reduced 5-state model (only VDI) are also shown 
(dashed lines). 
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ICa model identification 
We integrated the LTCC Markov model (Mahajan et al., 2008b) into the framework of the 
Shannon-Bers rabbit AP model (Shannon et al., 2004), and the ICa model was reparameterized 
using voltage-clamp data from previous studies in isolated ventricular myocytes from rabbit 
(Yuan et al., 1996; Linz & Meyer, 2000; Mahajan et al., 2008b), guinea pig (Hadley & Hume, 
1987; Zhong et al., 1997; Sonoda & Ochi, 2001), rat (Sun et al., 2000), and mouse (Sako et 
al., 1998). When available, we favored experiments obtained in rabbit at physiological 
temperature and solutions vs. other species and less physiological conditions. Results are 
shown for Ba current, and for Ca currents with and without SR Ca release. 
 Dependence of (normalized) current on Em is depicted in Fig. 7A-C. Simulated IBa and 
ICa (lower panels) peak at +5 mV, independent of charge carrier and SR function. At 5 mV, 
peak IBa equals -2.00 nA, peak ICa equals -2.14 nA and -2.17 nA with and without SR Ca 
release, respectively (vs. -2.06 nA at 0 mV, -1.98 nA at 0 mV, and -2.14 nA at +10 mV, in 
experiments (Mahajan et al., 2008b)). Normalized experimental current-voltage (I-V) curves 
are shown for comparison (upper panels) and exhibit some variability, possibly due to 
differences in species, intra- and extracellular solution compositions, and experimental 
protocols. 
 
 
 
 
Figure 8. Kinetics of LTCC current inactivation. Experimental (top) (Mahajan et al., 2008b) and 
simulated (bottom) IBa (A) and ICa (B) traces evoked by voltage pulses from -80 mV to -10 mV (left) and 
+20 mV (right). C) Experimental (left) (Mahajan et al., 2008b) and simulated (right) ratios of pedestal to 
peak current (IPed/IPeak) at varying times (indicated) during voltage pulses from -80 mV to various test 
potentials for ICa and IBa. Results for simulated IBa with a reduced 5-state model (only VDI) are also shown. 
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 Simulated current availability curves (Fig. 7D-F) indicate that inactivation is more 
complete the longer the inactivating pre-pulse, in agreement with experimental data (upper 
panels). A slightly U-shaped curve is obtained for IBa (Fig. 7D), with the largest inactivation 
corresponding to the largest Ba influx, near +5 mV, consistent with modest Ba-dependent 
inactivation (Brunet et al., 2009). Moreover, this U-shaped region is not seen with the reduced 
5-state model lacking IDI (dashed lines). Inactivation is more markedly U-shaped when 
simulating ICa (Fig. 7E-F), and is especially pronounced with SR function intact (Fig. 7E vs. 
F) as seen experimentally. 
 The kinetics of IBa and ICa inactivation can be assessed by the ratio of pedestal to peak 
current (IPed/IPeak) at different times after depolarization to different Em for experimental 
(Mahajan et al., 2008b) and simulated traces (Fig. 8C). Pedestal currents (and IPed/IPeak) 
decrease with longer pulses and inactivation is faster and deeper for ICa vs. IBa, and with larger 
ion influx and/or Ca release, in agreement with experiments (left panel). Again, the 
dependence of IPed/IPeak on Em is U-shaped (Fig. 8C) around the peak potential of 0~+10 mV 
(Fig. 7A and C) for both IBa and ICa. In contrast simulated IBa curves with the 5-state model 
(VDI) are relatively flat (dashed lines at right). Previous results have shown that IBa 
inactivation depends on Ba influx (Brunet et al., 2009). For a given peak current at different 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Kinetics of LTCC current 
inactivation. IBa (B), ICa without (C) 
and with (D) SR Ca release evoked by 
voltage steps from -80 mV to -10 mV 
(dashed lines) and +21 mV (solid). Step 
voltages were chosen symmetrically on 
the I-V curve (A). 
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Em, the kinetics of IBa inactivation are comparable. For example, experimental (Mahajan et 
al., 2008b) and simulated IBa at -10 and +20 mV reach similar peak values (simulated: -8.75 
and -9.12 A/F) and inactivate similarly (Fig. 8A). On the other hand, when SR Ca release 
occurs, for a given peak ICa, inactivation is faster at negative Em, where ECC gain and release 
are larger. For example, experimental (Mahajan et al., 2008b) and simulated ICa at -10 and 
+20 mV reach similar peak values (simulated: -9.58 and -10.1 A/F) but inactivation is much 
faster at -10 mV (Fig. 8B). This is further illustrated in Fig. 9, where Em values are chosen 
symmetrically with respect to peak current, such that the currents reach the same peak value 
and inactivation kinetics are easily compared. 
 Time constants of recovery from inactivation were assessed for IBa and ICa at various 
holding potentials, and are depicted in Fig. 10 with experimental results (Mahajan et al., 
2008b). Recovery is faster at more negative Em, with no differences between ICa and IBa. 
AP model validation 
We assessed the robustness of the model by validating it in more physiological settings 
against experimental AP-clamp data from isolated ventricular myocytes from rabbit (Yuan et 
al., 1996; Puglisi et al., 1999; Linz & Meyer, 2000) and guinea pig (Linz & Meyer, 1998). Ca 
influx via LTCC during an AP differs notably from that evoked by a square voltage pulse 
(Yuan et al., 1996), and our simulations confirm this (Fig. 11, left vs. right). ICa peaks and 
inactivates more slowly during an AP (Fig. 11B), but the current integral is larger at the end 
of the AP command pulse (Fig. 11C). Fig. 12B shows comparable simulated and experimental 
ICa (Linz & Meyer, 1998) elicited by APs with different amplitudes (Fig. 12A). ICa peak 
decreases as AP amplitude (and upstroke potential) increases. The reduced influx also causes 
slower inactivation in each case. 
 The time courses of IBa and ICa during an AP are depicted in Fig. 13B. When SR Ca 
release is prevented, ICa inactivates more slowly, and the integral of Ca influx through the 
channel is augmented (Fig. 13C). Furthermore, when addition of BAPTA is simulated, CDI is 
nearly absent, and ICa exhibits a prominent plateau and causes a much larger Ca influx. Model 
predictions agree well with experimental results reported in Fig. 13A-C, right panels (Linz & 
Meyer, 1998). In Fig. 13B and C, left, IBa is simulated with either the 7-state or the non-IDI 5-
state LTCC model. 
 
   
 
Figure 10. Recovery from inactivation. 
Experimental (symbols) and simulated (lines) time 
constants of IBa and ICa recovery from inactivation 
obtained at varying holding potentials. Recovery 
from inactivation assessed using a 250 ms long 
voltage-clamp pulse to +10 mV (P1) followed by 
repolarization to the various holding potentials for a 
variable time interval and a second pulse to 0 mV 
(P2). The time constant was estimated by fitting the 
recovery curve (ratio of the peak P2/P1 currents 
plotted as a function of recovery interval) to a 
monoexponential function. 
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 We also validated the comprehensive cellular AP and CaT model. To allow a direct 
comparison with existing rabbit models, time courses of AP and CaT (Fig. 14A), APD 
restitution properties (Fig. 14B), APD rate-adaptation (Fig. 14C) after sudden changes in 
cycle length, and frequency-dependent increase of systolic [Ca]i and [Na]i (Fig. 14D) obtained 
with our model are superimposed to those obtained with the Shannon-Bers (Shannon et al., 
2004) and the Weiss group (Mahajan et al., 2008b) AP models as compared in a recent study 
(Romero et al., 2011). Our model performs well when comparing simulated values of cardiac 
biomarkers (APD90, APD triangulation, slow time constant of the temporal APD90 adaptation 
to the accelerating rate, and maximal slopes of S1S2 and dynamic restitution curves) to the 
experimental (Table 3). Alternans were developed in our model at a pacing cycle length ≤180 
ms (Fig 14E).  
Analysis of inactivation mechanisms and sources of CDI 
To estimate the contribution of VDI and CDI to total inactivation and further validate the 
model, we reproduced the experimental GD-P protocol designed by Linz and Meyer (Linz & 
Meyer, 1998) and illustrated in Figs. 12B and 13D. This protocol, by interrupting the AP at 
different times (see Methods), reveals the fraction of channels inactivated during an AP (1-
availability; Fig. 12C-E). Fig. 13E-G show the progression of Ca channel inactivation during 
the AP and how VDI and CDI contribute to it (experiments at top and simulations at bottom). 
 
 
 
 
Figure 11. Differences between step and AP-clamp. Simulated (left) and experimental (right) 
(Yuan et al., 1996) Em (A), ICa (B), and running integral of Ca influx via LTCC (C). Simulated 
voltage step was from -80 mV to 5 mV, and AP waveform was obtained by pacing the virtual 
cell at 0.33 Hz to steady-state (with normal CaT). 
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 The time course of inactivation (Fig. 13E, lower panel) was assessed using this 
protocol for simulated ICa with and without SR Ca release and IBa. Fig. 13F shows the 
accumulation of CDI and VDI, estimated assuming that LTCC availability is the product of 
Ca- and voltage-dependent availability, as in (Linz & Meyer, 1998). The contribution of Ca 
released from the SR to ICa inactivation (CDISR) was calculated as the difference between 
 
 
 
Figure 12. Influence of AP amplitude on ICa inactivation. Simulated (left) and experimental (right) (Linz 
& Meyer, 1998) command APs with the same holding value and different amplitude (A) were used to evoke 
ICa (B). Simulated (C) and experimental (in guinea pig (Linz & Meyer, 1998) and rabbit (Linz & Meyer, 
2000), D and E respectively) time course of current availability (top) and inactivation (bottom) during APs 
with different amplitudes were obtained with the GD-P protocol depicted in B, inset. 
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Figure 13. Influence of Ca homeostasis on ICa during AP-clamp. AP waveform was obtained by pacing 
the virtual cell at 0.33 Hz to steady-state (with normal CaT). Simulated (left) and experimental (right) (Linz 
& Meyer, 1998) command AP (A), evoked current (B), and running flux integral (C) with normal CaT, 
without SR Ca release, and BAPTA. IBa was also simulated with the baseline model and a reduced 5-state 
(VDI only) model. Experimental (top) (Linz & Meyer, 1998) and simulated (bottom) time course of current 
inactivation (E-G) during an AP was obtained with the GD-P protocol depicted in D. E) Inactivation of ICa 
with CaT, ICa without SR Ca release, INS, and IBa. F) Experimental and simulated VDI, and CDI. G) 
Experimental and simulated CDISR and CDILTCC. 
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availabilities measured with and without SR Ca release (Fig. 13G). Finally, the contribution 
of Ca entry via ICa to inactivation (CDILTCC) was calculated by subtracting CDISR from CDI 
(Fig. 13G). We infer that SR Ca release accounts for most of CDI during the initial AP phase, 
whereas Ca through LTCC controls CDI later during the AP. Experimental results (Linz & 
Meyer, 1998) are shown in the upper panels of Fig. 13E-G. INS via LTCC was used 
experimentally to assess VDI, rather than using our 5-state VDI model (Fig. 2B). 
 
 
 
 
Figure 14. Dynamic properties of AP models. Electrophysiological activity simulated as in 
(Romero et al., 2011) for Shannon-Bers (thick black line), Mahajan et al. (thin black line), and our 
model (dashed grey): time course of steady-state AP (A, top panel) and CaT (A, bottom) at 2.5 Hz; 
S1S2 (B, top) and dynamic (B, bottom) APD (to 90% repolarization, APD90) restitution curves; 
APD rate adaptation (C) after sudden changes in cycle length (indicated), starting from steady-state 
conditions at 2.5 Hz; steady-state normalized systolic [Ca] (D, top) and [Na] (D, bottom) relative to 
value at 0.25 Hz as a function of the pacing frequency. E) Steady-state Em (top) and CaT (bottom) 
obtained by stimulating our model at 6.25 Hz. 
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 The importance of SR Ca release for CDI was also highlighted in AP-clamp 
experiments in rabbit ventricular myocytes at 35°C (Puglisi et al., 1999). Analogous to 
experiments, ICa traces evoked by APs subsequent to an initial SR depletion show increasingly 
faster inactivation (Fig. 15A-B) as the SR is replenished and SR Ca release increases (Fig. 
15C). Normalized integrals of ICa during each pulse reveal that inactivation due to SR Ca 
release decreases net Ca influx by about 40%, similar to experimental data (Fig. 15D). 
Effects of reduced VDI 
Changes in the VDI transitions caused a striking reduction in the SSI curve (Fig. 16A), and 
led to AP prolongation (Fig. 16B). Notably, this reduced VDI did not modify ICa during the 
early repolarization and initial plateau phase, but rather during late AP phases 2 and 3 (Fig. 
16C). Indeed, VDI monotonically increases during the AP and makes a larger contribution 
during repolarization (Fig. 13F vs. 16E). The time courses of CDISR and CDILTCC do not 
appear appreciably modified by removal of VDI (Fig. 16F). 
Effects of reduced CDI 
We assessed the effects of impaired CDI on the cardiac AP by simulating the expression of 
CaM1234, which eliminates CDI of native LTCCs by displacing WT CaM that is otherwise 
normally prebound to the channels. LTCC inactivation slowed with increasing expression of 
CaM1234 (Fig. 17A-B) (Alseikhan et al., 2002; Mahajan et al., 2008a), which caused 
significant AP prolongation (Fig. 17C), as reported experimentally (Alseikhan et al., 2002), 
e.g., larger than that produced by comparable reduction of VDI in Fig. 16. 
 When 20% of the channels have Ca-insensitive CaM prebound, the model predicts the 
occurrence of EADs, as shown in Fig. 17D and 18A. We monitored the time courses of LTCC 
open probability, the opening rate (dO/dt), and contributions to dO/dt of transitions between 
open and closed states (activation/deactivation) or open and inactivated states 
(inactivation/recovery) during a control AP (Fig. 19) and during the CaM1234-induced EAD 
(Fig. 20, left). Insets show enlargement of AP plateau near the EAD takeoff (i.e. when dEm/dt 
became positive during AP plateau). This phenomenon does not depend on ICa reactivation 
Table 3. Comparison of simulated and experimental biomarkers. APD90 is the APD at the 90% of 
repolarization; APDtri (APD triangulation) is the difference between APD90 and APD60 (Fig. 14A); τslow is 
the slow time constant of the temporal APD90 adaptation to the accelerating rate (Fig. 14C); slopemax, S1S2 and 
slopemax, Dyn are the maximal slopes of S1S2 and dynamic restitution curves (Fig. 14B, respectively top and 
bottom panels). Experimental range from (Romero et al., 2011). 
 
Biomarker 
Simulation Experimental 
range Shannon et al. 
Mahajan 
et al. Our model 
APD90 (ms) 177 185 167 120-190 
APDtri (ms) 18 37 15 26-32 
τslow (ms) 52 84 41 12-42 
slopemax, S1S2 (-) 3.8 4.3 3.42 3.3-6 
slopemax, Dyn (-) 4.1 0.96 0.36 1.5-2.5 
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(Figs. 18A-B and 20B-D, left). In fact, LTCC open probability progressively declines (dO/dt 
is always negative) during the entire AP plateau and EAD (Fig. 20D, left, inset); channels are 
leaving the open state. Instead, these EADs are likely to be due to enhanced Ca extrusion via 
inward Na-Ca exchanger (NCX) current (INaCa, Fig. 17F). This INaCa is due to enhanced SR Ca 
loading and spontaneous SR Ca release (Fig. 17J) and elevated sub-sarcolemmal [Ca] ([Ca]SL, 
Fig. 17H). We tested the role of INaCa by reducing NCX density instantaneously during the 
arrhythmogenic AP just before EAD takeoff. When INaCa was reduced by 10%, EAD 
amplitude was reduced (Fig. 17D and F, inset), whereas a 30% NCX reduction completely 
eliminated the EAD (Fig. 17D and F, inset). 
 As CDI reduction increased to 40% APD was further prolonged, but no EADs 
occurred (Fig.17C). Our explanation for the disappearance of EADs is that as CDI decreases 
the AP plateau potential becomes more depolarized, thus opposing inward INaCa (the more 
depolarized Em the less inward INaCa), which is not large enough to cause membrane 
afterdepolarization. 
 When the fraction of Ca-CaM insensitive channels was increased to 50%, the AP 
prolonged further (Fig. 17L) due to the increased depolarizing ICa (Fig. 17M), which also 
further loaded the SR with Ca (Fig. 17R). The high [Ca]SR causes a large spontaneous Ca 
release (Fig. 17R-S) which activates a large inward INaCa (Fig. 17N), sufficient to cause a 
 
 
 
 
Figure 15. Influence of SR Ca release on ICa inactivation. ICa traces (A) and SR Ca release fluxes (C) 
elicited by a train of 10 APs (as in Fig. 11A) after SR depletion at physiological temperature. B) Data at 
25°C were simulated by simply decreasing LTCC permeability by 50% (to show the effect of reduced Ca 
influx) rather than reparameterizing the whole AP model at room temperature. Insets show experimental data 
from (Puglisi et al., 1999). D) Normalized simulated (solid lines) and experimental (symbols) (Puglisi et al., 
1999) Ca influx integrals at every pulse (black 35°C, grey 25°C). 
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delayed afterdepolarization (DAD) and triggered AP (Fig. 17L). A second DAD occurs after 
the first triggered AP, but the spontaneous SR Ca release is slightly smaller, and fails to 
trigger an AP. 
Effects of IKr and IKs block 
We also examined AP prolongation due to complete block of both rapid and slow components 
of delayed-rectifier K current (IKr and IKs, Fig. 18E). As with the CaM1234-modified AP, we 
monitored the time courses of LTCC open probability and state transitions (Fig. 20B-D, 
right). In contrast with CaM1234 expression, under IKr and IKs block we clearly detected LTCC 
reactivation during EAD takeoff. In this case dO/dt turned positive (Fig. 20D, right, inset), 
indicating that more channels entered the open state (unlike the CaM1234 case). This ICa 
reactivation during the EAD was due to reopening from the closed state C1: while the 
transition between inactivated and open states (Fig. 20D, right, inset) moved negative 
(indicating inactivation did increase, i.e. negative dO/dt), that between closed and open states 
moved more strongly positive (indicating a more than compensatory reactivation, resulting in 
dO/dt>0). We looked also at the time courses of occupancy of the other states before EAD 
takeoff (Fig 21). While the occupancies of VDI states monotonically increased 
 
 
 
 
Figure 16. Effects of reduced VDI. A) Quasi-SSI curves depict the available IBa (5-state model) after 1000 
ms-long inactivation pre-pulses to the indicated voltages in control and reduced VDI conditions. Action 
potentials (B) and ICa (C) with normal CaT in control and reduced VDI conditions. D) Simulated time course 
of current inactivation during an AP with reduced VDI for ICa with CaT, ICa without SR Ca release, and IBa. 
E) Simulated VDI and CDI. F) Simulated CDI, CDISR and CDILTCC. 
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(Fig. 21F), we found a decrease in CDI states occupancies (Fig. 21E). This recovery of 
LTCCs from CDI caused the enhancement of C1 occupancy (Fig. 21C and G). 
ICa inactivation kinetics during EADs 
We next evaluated ICa inactivation during APs that showed EADs. We used GD-P protocols 
based on the two types of exemplar APs described above, obtained at 0.33 Hz, one with 20% 
expression of CaM1234 (Fig. 18A) and the other with complete block of IKr and IKs (Fig. 18E). 
 As experimentally observed (January & Riddle, 1989), in our simulations EAD 
amplitude inversely correlated with takeoff potential (the more negative the takeoff potential 
the larger the EAD amplitude, as indicated in Fig. 18A and E). ICa decayed smoothly 
throughout the CaM1234-induced EAD (Fig. 18B), whereas it exhibited a notch upon EAD 
initiation (Fig. 18F) with inhibition of K currents. Notably, a similar hump in ICa was detected 
experimentally (Yamada et al., 2008) during the same type of protocol in guinea pig 
ventricular myocytes (Fig. 18I and J). ICa inactivation increased monotonically during the 
CaM1234-induced EAD (Fig. 18C), and so did its Em- and Ca-dependent components (Fig. 18C 
and D respectively). On the other hand, with the EAD induced by K current block, ICa 
inactivation increased during the AP plateau, decreased slightly just before EAD takeoff, and 
increased again thereafter (Fig. 18G), as observed experimentally (Fig. 18K). In both 
simulations and experiments (Yamada et al., 2008), VDI did not display any clear notch (Fig. 
18G and K), whereas CDI showed a notch before EAD takeoff (Fig. 18H and L). Both 
CDILTCC and CDISR exhibited a hump prior to EAD initiation (Fig. 18H). This confirmed the 
recovery of LTCCs from CDI before EAD takeoff previously described. 
DISCUSSION 
In the present study we developed improved LTCC and SR Ca release models within the 
framework of the rabbit ventricular ECC model. Our main goal was to dissect the relative 
importance of VDI and CDI to total ICa inactivation during normal and abnormally prolonged 
APs. To differentiate VDI from CDI of macroscopic ICa, substitution of Ca with other charge 
carriers (e.g., Ba, (Zhong et al., 1997; Sako et al., 1998; Sun et al., 2000; Sonoda & Ochi, 
2001; Mahajan et al., 2008b) or Na and Cs (Hadley & Hume, 1987; Hryshko & Bers, 1992; 
Yuan et al., 1996)) has been widely used. In these studies, inactivation of IBa or INS has been 
assumed to reflect purely VDI. We sought to whether INS or IBa inactivation are a true measure 
of VDI for ICa and we found that INS inactivation at physiological temperature is faster (vs. ICa) 
and complete, perhaps reflecting some intrinsic difference vs. VDI occurring during ICa or IBa. 
Moreover, the main limitation to the use of IBa as a measure of VDI is its ability to modestly 
mimic CDI. Thus, we concluded that both approaches lead to an overestimation of VDI, and 
we constrained our LTCC model parameters by accounting for reduced, but not eliminated, 
IDI when Ba is the charge carrier. 
Inactivation of INS and IBa through the LTCC 
INS inactivates incompletely at room temperature (Hadley & Hume, 1987; Sun et al., 1997; 
Sun et al., 2000), but when the temperature was raised to 30°C the extent of inactivation was 
greater (Hryshko & Bers, 1992). Inactivation was even more complete at physiological 
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Figure 17. Effects of Ca-insensitive CaM overexpression. A) Experimental (Mahajan et al., 2008a) 
normalized currents evoked by a voltage step from -80 mV to +10 mV for ICa without SR Ca release (WT 
and CaM1234) and IBa. B) Simulated normalized ICa without SR Ca release (baseline, and with various degrees 
of impaired CDI). IBa traces are shown with the baseline model and a reduced 5-state model. C) Simulated 
AP obtained when pacing the digital myocyte at a basic cycle length of 3 s in baseline conditions and with 
various degrees (indicated) of impaired CDI. D-S) Simulated AP, ICa, INaCa, CaT, [Ca] in sub-sarcolemmal 
and cleft compartments, free SR Ca content and SR Ca release obtained when pacing the digital myocyte at 
a basic cycle length of 3 s in baseline conditions and with reduced CDI (20% reduction in D-K, and 50% in 
L-S). Insets in panels D and F show results obtained for the mutant condition by reducing instantaneously 
NCX density by 10% and 30%. 
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temperature (Fig. 4C vs. 4D). Mitarai and colleagues (Mitarai et al., 2000) also showed strong 
VDI of INS at physiological temperature (Fig. 5), and rescaling available experimental data to 
37°C gave comparable results. They explained some previous work reporting slower INS 
decay by suggesting that β-adrenergic stimulation could slow LTCC inactivation (as shown 
previously in (Yuan & Bers, 1995)). Indeed, when measuring INS in the presence of 
extracellular divalent cations (which partially block INS), isoproterenol was added to 
compensate for INS reduction (Matsuda, 1986; Linz & Meyer, 1998). However, since divalent 
cations can strongly block INS, it is debatable whether intrinsic INS gating can be measured in 
the presence of divalent cations in the bathing solution. 
 There are two tacit assumptions usually made when using INS as an experimental 
model to study ICa VDI: 1) the absence of IDI, which seems appropriate, and was recently 
confirmed (Brunet et al., 2009); 2) VDI of INS, IBa and ICa are the same process, which we 
now think may not be the case. 
 The substitution of Ba ions for Ca has been widely used to separate VDI from CDI of 
the macroscopic LTCC currents, and this is pragmatic because Ba produces only modest IDI 
(Ferreira et al., 1997; Brunet et al., 2009) and probably has similar (but not identical) binding 
properties to Ca in the pore. However, IBa inactivation depends on Ba flux, and it seems clear 
now that Ba can recapitulate a weak version of CDI. Ba is known to complex with CaM and 
activate interaction with CaM targets (Yamazaki et al., 1996; Ozawa et al., 1999), but its 
apparent affinity in other systems has typically been ≥100-fold lower than for Ca. While our 
change in rate constants that produces appropriate IBa IDI could be construed to represent only 
a ~10-fold reduction in affinity, this lower value should not be taken to imply an actual 
affinity difference in the classical biochemical sense. 
 To account for the moderate Ba-dependent inactivation, we have extended a 
previously published LTCC mathematical model of VDI and CDI into an ECC model 
(Mahajan et al., 2008b), and assessed whether and how experimental IBa inactivation results 
could be recapitulated by modifying CDI to account for Ba-dependent inactivation. We found 
that making 10-fold reductions in the Ca-dependent transition rates (in Fig 2) resulted in 
appropriate Ba-dependent IBa inactivation. Sun and colleagues (Sun et al., 2000) similarly fit 
their data of IBa by decreasing the Ba association constant to 10% of that of Ca. Thus their 
model suggested a smaller reduction of Ba affinity vs. Ca compared to another study (Ferreira 
et al., 1997), where the affinity for the inactivation site was reckoned to be ~100 times lower 
for Ba than Ca for CaV1.2 using a heterologous expression system. Reasons that the relatively 
modest 10-fold reduction in Ba- vs. Ca-dependent inactivation (vs. ≥100-fold expected for 
CaM binding) could have to do with: 1) the way CaM is prebound to the LTCC, 2) potentially 
weaker local Ba vs. Ca buffering, 3) higher single channel conductance for Ba, 4) dynamic 
considerations during current flow (Ba may equilibrate faster than Ca). In any event, given the 
Ba-dependent inactivation implemented here, one could derive a slower VDI model, which 
should be a more faithful representation of purely VDI during ICa. This may be an important 
distinction when one seeks to dissect the relative roles of Ca and Em in mediating normal 
function and pathophysiology (e.g., arrhythmogenesis). 
 Some studies in guinea pig ventricular myocytes showed similar inactivation of Ba, Sr, 
and Na currents (Findlay, 2002b), at least at room temperature. Analogously, Sun and 
colleagues (Sun et al., 2000) also reported similar inactivation τ for INS and IBa in rat 
cardiomyocytes (at room temperature), whereas INS (and ISr) inactivated more slowly than IBa 
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in human atrial cells at 23°C (Sun et al., 1997). Mahajan et al. measured IBa (and ICa) in rabbit 
cardiomyocytes at physiological temperature and reported that IBa inactivates incompletely 
with a monoexponential decay with τ ~150 ms (with little Em-dependence) in the absence of 
β-adrenergic stimulation (Mahajan et al., 2008b). Here, we found that INS inactivation is 
accelerated as temperature increases (especially at negative Em, where INS inactivation is 
slowest). Thus, we find that INS can inactivate more rapidly and completely than IBa, 
especially at physiological temperature (Fig. 5), suggesting that VDI that occurs during IBa (or 
 
 
 
Figure 18. ICa inactivation kinetics during phase 2 EADs. Kinetics of ICa (B, F and J) during AP-clamp 
with EAD-like stimuli (A, E and I) were assessed with the GD-P protocol. Total ICa (with and without 
release) inactivation (C, G and K), VDI, CDI (D, H and L), and CDISR and CDILTCC were computed with 
20% expression of CaM1234 (A-D), and block of IKr and IKs (E-H, simulations vs. experiments (Yamada et 
al., 2008), I-L). 
Model of L-type Ca Channel Inactivation 
66 Ph.D. Thesis 
ICa) must differ intrinsically from VDI during INS. During ICa and IBa flow, it is thought that 
the channel is essentially always occupied by at least one divalent cation occupying the pore 
(Yang et al., 1993), and this binding prevents monovalent permeation. We suggest that in the 
absence of divalent cation occupancy (during INS), VDI of the LTCC is fundamentally 
different, exhibiting steeper Em-dependence, which is faster than when divalent cations 
occupy the channel pore. This raises new questions of whether fast inactivation of INS is due 
to the absence of divalent cations that bind in the channel pore, or whether inactivation of 
inward INS differs from outward INS (e.g., due to the intracellular milieu). 
Inactivation of ICa during normal and abnormal AP repolarization 
In the first part of the study we found that neither IBa nor INS reflect pure VDI for ICa. Our 
modeling results predicted a detectable Ba-dependent inactivation (i.e. bell-shaped 
dependence on Em) when apparent Ba affinity for CaM is about one tenth than that of Ca. 
Nevertheless, if intracellular Ba accumulation is avoided (and if IBa amplitude is kept small), 
IBa is probably a better VDI model for ICa than is INS. Thus, we integrated the Markov model 
studied (Mahajan et al., 2008b) into the framework of the Shannon-Bers model of rabbit AP 
 
 
 
 
Figure 19. Insights into LTCC dynamics during normal repolarization. Time course of Em (A), ICa (B), 
LTCC open probability (C) and its rate of changes (D), and contributions to dO/dt of channel transitions 
between Open and Closed (O-C), Open and CD-Inactivated (O-CDI), Open and VD-Inactivated (O-VDI), 
and Open and Inactivated (O-VDI & CDI) during a control AP. Insets show the final portion of AP plateau 
(x axis limits are indicated with dotted lines in the main panels). 
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(Shannon et al., 2004) and we constrained LTCC model parameters by accounting for 
reduced, but not eliminated, IDI when Ba is the charge carrier, and adopted the reduced IBa 
model (5 lower states in Fig. 2B) to represent pure VDI. Moreover, the formulation of SR Ca 
release was modified to reproduce high ECC gain at negative Em. 
 The AP model developed reproduces faithfully experimental properties of ventricular 
myocytes, including: 1) the higher ECC gain at negative Em; 2) the kinetics of LTCC 
inactivation (measured with both voltage steps and AP-clamp) under different Ca homeostasis 
conditions and during EADs; 3) the SR Ca release contribution to ICa inactivation during an 
AP; 4) the effects of Ca-insensitive CaM expression; 5) the effects of delayed-rectifier K 
current inhibition. We used this improved model: 1) to predict the effects of removal of VDI, 
2) to study arrhythmogenic mechanisms in the presence of impaired CDI, and 3) to assess the 
involvement of ICa in EADs.  
 A recent study (Romero et al., 2011) investigated the differences between the 
Shannon-Bers and the Mahajan et al. models of the rabbit ventricular AP, and showed that the 
 
 
 
 
Figure 20. Insights into LTCC dynamics during abnormal repolarization. Time course of Em (A), ICa 
(B), LTCC open probability (C) and its rate of changes (D), and contributions to dO/dt of channel transitions 
between Open and Closed (O-C), Open and CD-Inactivated (O-CDI), Open and VD-Inactivated (O-VDI), 
and Open and Inactivated (O-VDI & CDI) during an EAD caused by either CaM1234 overexpression (left) or 
K current blockade (right). Insets show the time window corresponding to EAD takeoff (x axis limits are 
indicated with dotted lines in the main panels). 
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former performs better at slow rates, the latter at fast rates. We conducted a model evaluation 
taking into consideration frequency-dependency mechanisms, and showed that steady-state 
APD and Ca rate dependence (Fig. 14) are similar to those predicted by the parent Shannon-
Bers model, in good agreement with experimental data. Although we did not perform a 
systematic sensitivity analysis, we also expect the ionic mechanisms modulating 
electrophysiological properties to be similar. 
 We simulated the GD-P protocol to quantify the contributions of CDI and VDI to total 
inactivation, and to study the importance of different Ca sources involved in this process (Fig. 
13D-G), as in (Linz & Meyer, 1998). We found that ICa inactivation during an AP is 
predominantly CDI, which is mostly controlled by SR Ca release during the initial AP phase, 
but mainly by Ca entering through LTCCs for the remaining part. Linz and Meyer showed 
similar results in guinea pig cells, although they estimated a smaller contribution of the SR to 
CDI. Discrepancies between simulated and experimental results may be explained by the 
authors' choice of measuring INS to assess pure VDI, since we have shown this assumption 
leads to overestimation of VDI. Furthermore, there may be differences in LTCC control by Ca 
in guinea pig vs. rabbit myocytes. In fact, we found that ICa inactivation due to SR Ca release 
decreases net Ca influx by about 40%, which is just a little less than that which Puglisi and 
colleagues (Puglisi et al., 1999) showed in rabbit myocytes (Fig. 15). 
 We based our analysis of CDI and VDI on the classic Hodgkin and Huxley 
formulation, where the activation and inactivation gating parameters do not represent specific 
kinetic states of ion channels, are independent, and their product modulates the current (as ICa 
in the original Shannon-Bers model, inherited from the Luo-Rudy model (Luo & Rudy, 
1994a)). However, the structure of the Markov model here adopted (Mahajan et al., 2008b) 
allowed us to discriminate the contributions of CDI and VDI by monitoring transitions from 
the open state to closed and inactivated states (Figs. 19 and 20), as further discussed below. 
 Several computational studies have acknowledged the importance of developing a 
detailed kinetic model of LTCC (Imredy & Yue, 1994; Jafri et al., 1998; Sun et al., 2000; 
Findlay, 2002b; Findlay, 2002a; Faber et al., 2007; Mahajan et al., 2008b; Hashambhoy et al., 
2009), due to its fundamental role in ECC in cardiac myocytes (Bers, 2001). Imredy and Yue 
first introduced a Ca-dependent mode ("Ca mode") to separate CDI and VDI in a rat LTCC 
model (Imredy & Yue, 1994), which was extended by Jafri and colleagues with two mirroring 
"normal" and a "Ca" gating mode structures (Jafri et al., 1998). Faber et al. conserved the 2-
mode "mirror" structure with a more complex description of the inactivation pathways (Faber 
et al., 2007), whereas the Weiss group proposed the minimal Markov LTCC formulation that 
is extended in the present paper (Mahajan et al., 2008b). The latter models were accompanied 
by improved formulations of SR Ca release and integrated into existing AP models 
(respectively, guinea pig (Luo & Rudy, 1994a) and rabbit (Shannon et al., 2004)). In both 
models IBa was used for fitting of VDI. Faber et al. and Mahajan et al. found that CDI plays a 
greater role at negative Em during voltage pulses, due to higher ECC gain. In fact, the Weiss 
group indicated that CDISR is more important at negative voltages, while Ca entering the cell 
dominates CDI at positive Em (Mahajan et al., 2008b). As for the time course of inactivation, 
the Rudy group reported an early dominance of SR Ca release in controlling CDI, and a late 
dominance of sarcolemmal Ca influx, in agreement with our findings with AP-clamp (Faber 
et al., 2007). 
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 The need for a faithful characterization of the roles of VDI and CDI has been 
underlined by experimental studies showing the deleterious effects of inhibiting one of the 
two mechanisms. The Yue group showed the effects of CaM1234 expression, which inhibits 
CDI and produces dramatic AP prolongation (Alseikhan et al., 2002), whereas the Keating 
group showed the effects of the G406R mutation that removes VDI and is linked to the 
Timothy syndrome (Splawski et al., 2004). The effects of Timothy syndrome have been 
investigated in simulation studies (Faber et al., 2007; Zhu & Clancy, 2007; Thiel et al., 2008; 
Sung et al., 2010). The notion that gene mutations linked to disease may interfere both with 
VDI and CDI is intriguing (Yarotskyy et al., 2009), although not yet fully understood. Also, 
shifts in VDI could alter intracellular Ca handling and signaling, which could in turn 
contribute to the Timothy syndrome phenotype (Thiel et al., 2008). In this study, removing 
VDI, while retaining CDI, caused AP prolongation (Fig 16). Notably, when simulating the 
expression of CaM1234, which removes CDI without affecting VDI (Alseikhan et al., 2002), 
we predicted a much more marked APD prolongation (Fig. 17), confirming previously 
observed experimental (Alseikhan et al., 2002) and simulation (Mahajan et al., 2008a) results. 
 
 
 
 
Figure 21. Insights into LTCC dynamics during EAD induced by K currents block. 
Time course of Em (A) and occupancy of the LTCC Markov model states (B-F) during an 
EAD caused by K current blockade. Insets show the time window corresponding to EAD 
takeoff (x axis limits are indicated in the main panels). Panel G shows the rate of change of 
C1 occupancy (dC1/dt), and contributions to dC1/dt of channel transitions between C1 and 
Open (C1-O), C1 and C2 (C1-C2), C1 and VD-Inactivated (C1-Iv1), and C1 and CD-
Inactivated (C1-Iion1). 
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 We predicted the occurrence of EADs when CDI was reduced, or with further CDI 
reduction, DADs. The latter occurred when residual CDI was small enough so that added Ca 
influx caused SR Ca overload and spontaneous release, with consequent activation of enough 
transient inward NCX current to depolarize the membrane beyond threshold (Priori & Corr, 
1990). With a smaller reduction in CDI, not sufficient to harmfully overload the cell, EADs 
occurred during the AP plateau (phase 2). Depolarization during phase 2 EADs has been 
attributed to reactivation of ICa (January & Riddle, 1989; Luo & Rudy, 1994b; Zeng & Rudy, 
1995; Yamada et al., 2008). However, in our simulation of CaM1234 overexpression, ICa did 
not reactivate, but rather continued to inactivate (Fig. 20B-D, left). NCX is typically 
considered responsible for EADs occurring in AP phase 3 (Luo & Rudy, 1994b; Milberg et 
al., 2008), where the more negative Em and increased [Ca]i due to spontaneous Ca release 
both favor inward exchange current. Here, we predicted that changes in Ca cycling due to 
reduced CDI caused greater Ca extrusion, spontaneous SR Ca release (relying on the modified 
description of RyR gating), and sufficient inward NCX current to cause frank depolarization 
(Fig. 17). In support of this, when reduced NCX activity was imposed in the simulation, the 
EAD disappeared (Fig. 17D and F, insets). Indeed, Priori and Corr proposed that EADs and 
DADs might share the same mechanism (Priori & Corr, 1990), with NCX-mediated inward 
current being involved also in the genesis of EADs, as proposed for example in cardiac 
hypertrophy (Sipido et al., 2000). 
 Phase 2 EADs most typically occur when repolarization is prolonged due to alterations 
in K or Na currents. We obtained a phase 2 EAD due to ICa reactivation by blocking IKr and 
IKs (Fig. 18), and used this AP waveform to analyze the kinetics of ICa during abnormal 
repolarization, as done experimentally by (Yamada et al., 2008). They have suggested that 
EADs occur because ICa fails to completely deactivate, as opposed to significantly recovering 
from CDI, but our simulations highlighted the importance of recovery from CDI. EADs we 
obtained with IKr and IKs blocked were driven by LTCCs reactivating from the closed state C1 
(Em-independent transition, Fig. 2B) and not by a direct reopening from either inactivated 
state (Fig. 20D, right). However, our study showed that the enhancement of C1 occupancy 
before the EAD takeoff was mainly due to a decrease in CDI states occupancy (Fig. 21). 
Moreover, in our simulations with the GD-P protocol we found that ICa inactivation exhibited 
a notch before EAD takeoff, whereas VDI did not (Fig. 18G), as was also found 
experimentally (Yamada et al., 2008). We found that also CDI (including both CDISR and 
CDILTCC components) had a notch, confirming the occurrence of recovery from CDI. 
Conclusion 
An improved LTCC Markov model has been developed by taking into account a small 
contribution of IDI (in addition to pure VDI) when Ba is the charge carrier, in order to 
describe more faithfully contributions of CDI and VDI to total ICa inactivation. This model 
allowed us to investigate realistically the effects of CDI changes in normal and prolonged 
APs. We predicted that CDI is crucial for AP repolarization (while VDI is less so), and 
showed that impairment of ICa CDI may be arrhythmogenic by affecting intracellular Ca 
cycling, through its effect on the time course of LTCC Ca fluxes and thus NCX. We conclude 
that our improved model is a useful tool to study the role of ICa kinetics during normal and 
altered repolarization at the single cell level, and given its computational tractability it could 
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be incorporated in tissue-scale/whole heart models to test how these cellular instabilities can 
induce arrhythmias. 
 Further work will be required to incorporate modulation of ICa gating by other 
molecules involved in its regulation, such as protein kinase A and Ca-CaM dependent protein 
kinase, as has been described in previous studies (Findlay, 2002a; Saucerman et al., 2003; 
Saucerman & Bers, 2008; Hashambhoy et al., 2009; Hashambhoy et al., 2010; Soltis & 
Saucerman, 2010; Yang & Saucerman, 2012). 
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CHAPTER 3 
Arrhythmogenic Consequences of the Crosstalk 
between β-Adrenergic and CaMKII Signaling in a 
Murine Model of Heart Failure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Short title: Crosstalk between βAR and CaMKII Signaling in HF. 
___________________________________________________________________________ 
The following authors have contributed to the study presented in this chapter: 
 
Grandi E 1, Edwards AG 2, McCulloch AD 2 & Bers DM 1. 
 
 1 University of California in Davis, CA, USA 
 2 University of California in San Diego, CA, USA 
   
Crosstalk between βAR and CaMKII Signaling in HF 
76 Ph.D. Thesis 
Abstract 
Alterations in myocyte neurohumoral regulation, ion currents, Ca handling, and contractility, 
accompanied by ventricular hypertrophy and structural remodeling, all contribute to heart 
failure (HF). Ca-calmodulin dependent protein kinase (CaMKII) is upregulated and more 
active in HF, and is a key regulator of cellular subsystems contributing to acute mechanical 
and electrical dysfunction as well as chronic cardiac remodeling in HF. CaMKII 
overexpression (CaMKII-OE) leads to HF in mice, while CaMKII knockout or inhibition can 
protect against failure. In HF β-adrenergic tone is upregulated as well, and can activate 
CaMKII via protein kinase A (PKA) dependent or independent signaling pathways. We 
developed a new mathematical model of excitation-contraction coupling (ECC) in the murine 
ventricular myocyte, based on a previously validated rabbit action potential (AP) model that 
integrates the effects of CaMKII and PKA phosphorylation. We modified the description of 
cell geometry, ion channel, Ca and Na transporter expression and function, and CaMKII and 
PKA phosporylation effects to account for the experimentally observed differences of mouse 
vs. rabbit cardiomyocytes, and the most recent experimental data from murine ventricular 
myocytes recorded at physiological temperature. The model was validated in control 
condition against the experimentally observed frequency response of Ca dynamics, [Na], AP 
shape and duration. Then we validated the effects of CaMKII-OE and of PKA activation in 
control condition. When simulating PKA activation in CaMKII-OE condition, the model 
predicts arrhythmogenic activity, due to spontaneous Ca release from the sarcoplasmic 
reticulum that triggers the inward flux of the Na-Ca exchanger. Our model provides a useful 
quantitative framework to examine how CaMKII and PKA signaling pathways interact to 
coordinate ECC and arrhythmia in the context of HF. For example, it can be used to test 
which CaMKII targets are most arrhythmogenic or to assess the effects of acute vs. chronic 
CaMKII hyperactivity. Moreover, a systematic framework accounting for 
electrophysiological differences among species could be developed to extrapolate findings in 
the genetically engineered mice to the clinical setting. 
INTRODUCTION 
Heart failure (HF) is a pathology characterized by the inability of the heart to provide 
sufficient pump action to meet circulatory demand, usually associated to many symptoms 
including shortness of breath, leg swelling, and exercise intolerance. HF is a rapidly growing 
health problem, now approaching important proportions in industrialized societies (Lloyd-
Jones et al., 2009), where around 2% of adults is affected (McMurray & Pfeffer, 2005), and 
the fraction increases until 6 to 10% among over-65 people. Moreover, the estimated cost of 
HF is high (currently about 2% of the total healthcare spend in developed societies) and it is 
expected to rise (McMurray & Stewart, 2000). HF phenotype presents alterations in electrical 
conduction, energy metabolism, myocyte ion currents, Ca handling, contractile function and 
their neurohormonal regulation, accompanied by ventricular hypertrophy and structural 
remodeling (Jessup & Brozena, 2003; Stanley et al., 2005). About half of HF deaths are due 
to pump failure and half to arrhythmias, especially tachyarrhythmia. To treat these 
phenomena, the use of implantable devices has been often preferred to pharmacologic 
therapy, and this is mainly due to an inadequate understanding of fundamental mechanisms of 
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arrhythmogenesis in the large number of disease states which culminate in HF (Wang & Hill, 
2010). 
 The last decades have seen rapid advances in the understanding of the genetic and 
physiological processes, mainly as a result of the diffusion of animal modeling. The aim of 
this kind of research is to create a simplified framework (if compared to the human pathologic 
phenotype) where to study only one of the features characterizing an extremely complex 
syndrome like HF. At the same time, working with animal models, as opposed to isolated 
organs or cells, allows to analyze the physiological effects of cardiac dysfunction on a wider 
scale. Depending on the feature to investigate, different techniques have been adopted to 
create animal model of HF: surgical intervention (like banding an aorta or clipping a coronary 
artery), administration of a single toxin or drug, or genetic manipulation of the animal 
genome. In particular, this last approach has been developed and applied to individually 
investigate the changes in gene expression associated with HF by targeted 
mutagenesis/transgenesis or pharmacology (Breckenridge, 2010). Another key decision is the 
choice of animal species. Mouse models have been generally preferred to other bigger 
mammalian models (often presenting more similarities with the human physio-anatomy) due 
to the relatively complete annotation and simple manipulation of the murine genome 
(Breckenridge, 2010), and their relative inexpensiveness and practicality. Despite the 
differences between mouse and human (Bers, 2001; Kaese & Verheule, 2012), mouse models 
are now indispensable tools in many areas of medical research and the common features of 
murine and human hearts have allowed for many important observations regarding 
embryology, physiology, cell signaling, energetics and stem cell function (Breckenridge, 
2010). Indeed, mouse models are able to recapitulate major clinical features of HF with 
specifically defined molecular triggers and, up to now, over 5000 cardiac transgenic/knockout 
studies have been published (Breckenridge, 2010). The wealth of data on alterations in cell 
 
 
 
 
Figure 1. Schematic representation of CaMKII and PKA targets in mouse ventricular myocytes. 
Modified from (Bers & Grandi, 2009). 
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signaling, electrophysiology, Ca handling, myofilament function and tissue structure that can 
be measured in these mice cannot be obtained in humans, but integrative models provide a 
systematic framework to extrapolate findings in the genetically engineered mouse to the 
clinical setting. 
 The use of mouse models has proven useful in the study of the signaling network of 
Ca-calmodulin dependent protein kinase (CaMKII), that is believed to contribute significantly 
to acute mechanical and electrical dysfunction as well as chronic cardiac remodeling in HF 
(Bers & Grandi, 2009). CaMKII, a key nodal point in modulating the excitation-contraction 
coupling (ECC), is upregulated and more active in HF, as experimentally observed in human 
(Hoch et al., 1999; Ai et al., 2005). Moreover, cardiac myocyte-specific overexpression (OE) 
of CaMKII leads to a severe HF and arrhythmias in mice (Zhang et al., 2003), while CaMKII 
knockout or inhibition can protect against decompensation in HF in mice. In fact, CaMKII 
influences ECC by affecting several electrical and Ca-handling proteins (Maier & Bers, 2007; 
Bers & Grandi, 2009), and, by exerting multiple effects on numerous targets, can 
simultaneously favor HF and arrhythmias (Fig.1), as observed in transgenic CaMKII mice 
(Wagner & Maier, 2006; Sag et al., 2009). It has been shown that CaMKII alters the gating of 
L-type Ca current (ICa) (Yuan & Bers, 1994), ryanodine receptors (RyRs) (Guo et al., 2006), 
Na and K currents (Wagner et al., 2006; Wagner et al., 2009). Moreover, CaMKII 
phosphorylation of phospholamban (PLB) releases its inhibition on Ca-sensitivity of SR Ca 
pump (SERCA) (Odermatt et al., 1996), thus causing an increase in the pump affinity for Ca. 
 Elevated levels of circulating catecholamines is a hallmark of human congestive HF, 
resulting in chronic activation of the β-adrenergic (βAR) pathway and consequent loss of βAR 
sensitivity (Wehrens et al., 2004). βAR regulation of ECC is initiated by the coupling 
between βAR receptor and the stimulatory G protein, and the subsequent stimulation of 
adenylyl cyclase (AC), which synthesizes the cyclic adenosine monophosphate (cAMP). 
cAMP activates protein kinase A (PKA), that phosphorylates a wide spectrum of target 
proteins (Fig. 1) including L-type Ca channels (LTCCs), RyRs, and PLB (Grandi & Bers, in 
press). Thus βAR stimulation can influence CaMKII (whose activity responds to the 
frequency and magnitude of Ca signals) via the PKA-dependent enhancement of ICa and 
sarcoplasmic reticulum (SR) Ca uptake and consequent increase in SR Ca release and Ca 
transient (CaT) amplitude. More recently, other PKA-independent mechanisms have been 
postulated (see Discussion and Fig. 1). 
 The use of mathematical models has been notably successful in contributing to 
understand the mechanisms regulating the ECC and the underlying arrhythmogenic activities, 
but none of the different mouse models available in literature (Bondarenko et al., 2004; 
Demir, 2005; Shin et al., 2008; Wang & Sobie, 2008; Koivumaki et al., 2009; Li et al., 2010; 
Li et al., 2011; Li et al., 2012; Yang & Saucerman, 2012) presents a satisfactory description 
of both CaMKII and PKA signaling pathways. In the area of CaMKII signaling pathway 
description, some groups recently published models linking CaMKII to ECC in different 
mammalian models (Hund & Rudy, 2004; Iribe et al., 2006; Grandi et al., 2007; Livshitz & 
Rudy, 2007), though in all cases the focus was on consequences to ECC, with only limited 
representation of CaMKII activation mechanisms. The first model with an explicit inclusion 
of calmodulin (CaM) in the CaMKII pathway has been recently developed (Saucerman & 
Bers, 2008); it incorporates compartmental Ca, CaM, CaMKII and phosphatases, including 
calcineurin (CaN), based on measured concentrations, binding kinetics and target 
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phosphorylation, into the framework of a strongly validated rabbit ventricular AP model 
(Shannon et al., 2004). As far the βAR stimulation is concerned, the McCulloch group was 
arguably the first to develop a detailed mechanistic biochemical model of PKA signaling and 
its regulation of rabbit ECC (Saucerman et al., 2004), which was initially developed for the 
rat ventricular myocyte (Saucerman et al., 2003; Saucerman & McCulloch, 2004). The 
Saucerman group (Soltis & Saucerman, 2010) integrated the model of PKA signaling 
(Saucerman et al., 2004) with the model of CaMKII signaling (Saucerman & Bers, 2008) into 
the Shannon-Bers model of rabbit AP (Shannon et al., 2004). Recently the same group 
developed a murine AP model (Yang & Saucerman, 2012) updating the description of the 
PKA activation. 
METHODS 
In order to study how βAR stimulation and CaMKII signaling interact in ECC regulation in 
context of HF in mouse ventricular myocytes, we integrated the most recent descriptions of 
CaMKII (Saucerman & Bers, 2008) and PKA (Yang & Saucerman, 2012) signaling pathways 
into a newly parameterized murine ECC model. In particular we started from the Soltis-
Saucerman rabbit AP model (Soltis & Saucerman, 2010), built upon the Shannon-Bers model 
framework (Shannon et al., 2004). We took into account all the differences observed in mouse 
vs. rabbit cardiomyocytes (Bers, 2001), and the most recent experimental data from murine 
ventricular myocytes, regarding cell geometry, ion currents, Ca and Na handling and CaMKII 
phosphorylation effect. Parameters were manually fitted to experimental measurements 
recorded at physiological temperature. Data obtained at room temperature have been scaled at 
 
Table 1. Summary of geometric differences between rabbit and mouse ECC models. 
 
Geometry Rabbit Mouse 
Volume 
Vtot (pL) 33 
Vcyt (pL) 65% Vtot 
VSL (pL) 0.2% Vtot 
Vj (pL) 0.0539% Vtot 
VSR (pL) 3.5% Vtot 
Surface 
Atot (cm2) 1.46e-4 2e-4 
FSL (-) 89% 81% 
ASL (cm2) FSL Atot 
Fj (-) 11% 19% 
Aj (cm2) Fj Atot 
Junctions (#) 20150 46627 
Spacing (μm) 1.2 0.93 
Diffusion 
dxj-SL (μm) 0.5 0.3 
Aj-SL (μm2) 303 703 
dSL-cyt (μm) 0.45 
ASL-cyt (μm2) ASL 
Surface/Volume (pF/pL) 4.1848 6.0606 
Capacitance (pF) 138.1 200 
Dishomogeneous 
distribution 
Fj, LTCC (-) 90% 
Fj, NKA (-) 11% 23% 
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Figure 2. Rabbit vs. mouse electrophysiology. AP, CaT and underlying ionic currents in the rabbit (left 
column) and mouse (right) ventricular myocyte models paced at 1 Hz in control condition. 
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37°C using different Q10 factors derived from literature (Xu et al., 1999; Brouillette et al., 
2004). The model has been validated in control condition against the experimentally measured 
frequency response of Ca dynamics, [Na], AP shape and duration. The effects of 6-fold 
CaMKII-OE have been evaluated, as well as the effects of βAR activation. To this end, we 
substituted the original description of PKA activation (Saucerman et al., 2004; Soltis & 
Saucerman, 2010) with the updated fully ordinary differential equations (ODEs) 
implementation of the βAR stimulation developed in the Yang-Saucerman model of murine 
ventricular AP (Yang & Saucerman, 2012), with appropriate adaptations to the Shannon-Bers 
model framework. We studied the consequences of PKA activation in both control and 
CaMKII-OE conditions by simulating the application of the agonist isoproterenol (ISO) at a 
concentration of 100 nM. The fully integrated model is a system of ODEs implemented in 
MATLAB (Mathworks, Natick, MA, USA) and solved numerically using a variable order 
solver (ode15s). 
RESULTS 
Cell geometry 
Compared to rabbit, murine ventricular cell presents an increased surface area (Satoh et al., 
1996), while the volume is unchanged; consequently the membrane capacitance increases 
(Knollmann et al., 2000). Mouse presents a bigger fraction of transverse-tubules (t-tubules) in 
junctions (Page & Surdyk-Droske, 1979). This change, together with the increase in total 
surface area, leads to an increase in the junctional surface, hence to an increase of the number 
of junctions and a decrease of the distance among them (Li et al., 2012). We assumed 
homogeneous distribution of channels and transporters, except LTCCs (90% in junctions as in 
rabbit) and Na-K pump (NKA, 23% in junctions). In fact, it has been shown that in murine 
ventricle the total pump density is about 60% higher in t-tubules vs. external sarcolemma 
(Berry et al., 2007). Table 1 offers a more detailed overview of the geometric differences 
between rabbit and mouse models. 
K currents 
Mouse and rabbit ventricular APs differ significantly (Nerbonne, 2004), in that the former is 
characterized by triangular shape (absence of plateau) and brief duration (~35 ms), whereas 
the latter lasts hundreds of ms and exhibits a prominent plateau phase (Fig. 2). These 
differences are mainly explained by different expression of repolarizing K currents (Fig. 2). 
 In mouse ventricular myocyte the transient outward K current (Ito) is composed mainly 
by the fast component (Ito,fast), which is highly expressed, whereas the slow component 
(Ito,slow) has been shown to be expressed only in the septum (Guo et al., 1999). We modified 
Ito density and kinetics to fit a set of voltage-clamp data (scaled at physiological temperature) 
that includes the peak current-membrane potential (Em) relationship (I-V, Fig. 3A), steady-
state activation and inactivation (SSA and SSI, Fig. 3C), time constants of activation (τact, Fig. 
3AB), inactivation and recovery from inactivation (τinact, Fig. 3D). When the murine Ito is 
included in the Soltis-Saucerman model, the plateau level decreases and the AP shortens (Fig. 
3L). 
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 Also the slow delayed rectifier current (IKs) is absent in mouse ventricular cell 
(Nerbonne, 2004), where two others K currents (both absent in rabbit ventricular cell) are 
expressed: a rapidly activating and slowly inactivating current (IKur) and a non-inactivating 
 
 
 
Figure 3. Characterization of murine K currents: Ito, IKur, Iss and IK1. Experimental (symbols) and 
simulated (solid lines) I-V relationship (Ito in panel A, IKur in E, Iss in I, IK1 in K), time constant of activation 
(Ito in B, IKur in F, Iss in J), SSA and SSI (Ito in C, IKur in G), time constant of inactivation and recovery from 
inactivation (Ito in D, IKur in H). Simulated rabbit AP changes as more mouse-like features are progressively 
included (L). Experimental data from (Wang & Duff, 1997; Zhou et al., 1998; Xu et al., 1999; Knollmann et 
al., 2000; Brouillette et al., 2003; Zhou et al., 2003; Brouillette et al., 2004; Brunet et al., 2004; Wagner et 
al., 2009) or provided by the Nerbonne group. 
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steady-state current (Iss). These two currents share the same SSA function (Fig 3G), with 
markedly different time constants of activation (Fig. 3F and J). We integrated their 
descriptions as formulated by the Smith group (Li et al., 2010), and modified the parameters 
to fit the experimental observed I-V, SSA, SSI, τact and τinact (Fig. 3E-J). Recent findings by 
the Nerbonne group showed that IKur has two different components (IKur,fast and IKur,slow), 
characterized by different time constants of inactivation and with almost the same densities 
 
 
 
 
 
Figure 4. Characterization of NCX and SERCA functions. Experimental (symbols) and simulated (solid 
lines) Ca-dependence of NCX (panel A) and SERCA (B) fluxes. Simulated caffeine-induced CaT after 
steady-state stimulation at 1 Hz (C); inset shows the experimental recording. Caffeine application was 
simulated in absence of external stimulation, forcing the SR Ca release by enhancing the RyR open 
probability and inhibiting the SERCA function. Relative contributions of SERCA, NCX and plasma 
membrane Ca pump (PCA) to [Ca]i decay during a normal twitch (D) and during a caffeine-induced CaT 
(E). Experimental data from (Su et al., 1998; Antoons et al., 2002; Maier et al., 2003; Li et al., 2010; 
Dybkova et al., 2011; Li et al., 2011). 
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(respectively 53.3 and 46.7% of the total IKur). Thus, we modified the original formulation 
introducing the differentiation in the two components (Fig. 3H). The inclusion of IKur and Iss 
eliminates the AP plateau and further shortens the AP (Fig. 3L). 
 Magnitude of the inward rectifier K current (IK1) was reduced (Fig. 3K) compared to 
rabbit, causing a prolongation of the AP phase 3 (Fig. 3L). 
Ca and Na handling 
Despite the shorter duration of the AP and the reduced extracellular [Ca] (1 vs. 1.8 mM), the 
Ca influx in mouse is comparable with the one seen in rabbit. In agreement with experimental 
data (Li et al., 2011; Li et al., 2012), the density of ICa has been increased to reproduce the 
peak current (Fig. 2) and the Ca influx during an AP (0.1 pC/pF). 
 SERCA and Na-Ca exchanger (NCX) have been tuned to reproduce the Ca-
dependence of their fluxes (Fig. 4A and B) and their relative contributions to the Ca efflux. 
We simulated caffeine application after steady-state stimulation at 1 Hz (Fig. 4C), to analyze 
the intracellular [Ca] ([Ca]i) decay during both a physiological twitch and a caffeine-induced 
CaT. The model was set to reproduce the time to half [Ca]i decay experimentally observed in 
both cases. In agreement with experimental data (Li et al., 1998), SERCA is the major 
contributor to cytosolic Ca removal in normal condition, whereby NCX extrudes most of the 
released Ca (about 90%) after caffeine application. 
 Na current (INa) has been modified to fit the AP upstroke velocity (Edwards et al., 
unpub.) and inactivation data (Wagner et al., 2006). We modified SR leak current, Ca and Na 
background currents to obtain the proper Na and Ca concentrations at rest. We increased Na 
affinity for NKA and pump density in agreement with functional experimental data (Berry et 
al., 2007). Moreover, the resting Na influx has been increased, since it has been 
experimentally shown that the resting Na influx in rat is about 3 times bigger than in rabbit 
(Despa et al., 2002). Simulating strophanthidin application (resulting in a complete inhibition 
of NKA function) at rest, we obtained a diastolic Na influx of 2.27 mM/min (not shown). 
CaMKII and PKA effects 
Table 2 summarizes the regulatory effects of CaMKII and PKA phosphorylation included in 
the model. Both pathways dynamically regulate key Ca handling targets including LTCC, 
PLB and RyR, and thus influence Ca signaling by increasing ICa magnitude, SR Ca uptake 
and release. Phosphorylation of LTCC is thought to cause channel facilitation, which is 
manifested as a slight increase in peak current and slower inactivation (Kohlhaas et al., 2006). 
RyR are hypersensitive upon CaMKII phosphorylation, which causes increased diastolic Ca 
leak (via Ca sparks). PLB is more expressed in mouse vs. rabbit (Yang & Saucerman, 2012), 
and its phosphorylation releases the inhibition of SERCA, increasing the affinity of this pump 
for intracellular [Ca]. 
 Although CaMKII is present in all cytosolic compartments, its activation can occur 
only in the dyadic space, where [Ca]i reaches much higher levels than in the bulk cytosol. 
When increasing the pacing rate, dyadic CaMKII activity (Fig. 5A) and consequent target 
phosphorylation increase (Fig. 5B and C). Each target is characterized by different 
phosphorylation kinetics (Fig. 5B): LTCCs get phosphorylated very rapidly, RyRs more 
slowly, and PLB very slowly. Time-averaged steady-state phosphorylation levels are also 
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sensitive to the amount of CaMKII expression level (Fig. 5C). While CaMKII-mediated 
effects on ICa, RyR and PLB were not changed in mouse vs. rabbit, we adapted the 
phosphorylation effects on other targets, which dynamics are not considered, to murine 
physiology (according to experimental data). In mouse, CaMKII phosphorylation affects Ito,fast 
by decreasing the magnitude by about one third, and by decreasing (-38%) the time constant 
of recovery from inactivation (Wagner et al., 2009). In the same study, IK1 was found reduced 
by 50% in CaMKII-OE condition. We incorporated these changes in the model. Moreover, we 
increased the diastolic Na influx (simulated strophanthidin application results in a diastolic Na 
influx of 3.4 mM/min vs. 2.27 mM/min in WT) and the effect of CaMKII phosphorylation on 
peak and late INa in agreement with experimental data (Wagner et al., 2006). 
 The description of PKA activation has been integrated as developed for mouse in the 
Yang-Saucerman model. Compared to rabbit, βAR receptors are less expressed in mouse 
ventricular myocytes, while the concentration of total AC is increased. PKA phosphorylation 
of troponin I (TnI) decreases myofilament Ca sensitivity in mouse as in rabbit. PKA 
phosphorylates also phospholamman (PLM), leading to an increase in the affinity of NKA for 
internal Na, with no effect on the maximum pump rate (Despa et al., 2005). Moreover, we 
integrated into the Yang-Saucerman formulation the dynamic regulation of IKur, whose 
magnitude increases by 20% after 100 nM ISO application (Li et al., 1996). Regulation of IKs 
and cystic fibrosis transmembrane conductance regulator current were not included here as 
mouse ventricular myocytes do not express these channels. 
Model validation in WT and CaMKII-OE conditions 
We validated the baseline mouse model against a wide set of experimental data measured at 
different stimulation frequencies and obtained good agreement as shown in Fig. 6. Fig. 6A 
Table 2. Summary of included functional ECC regulation modules. All regulatory effects - except those 
ones indicated by (*) - are described using a mathematical formulation that differentiates the 
phosphorylation dynamics of each target. Modified from (Soltis & Saucerman, 2010). 
 
Target CaMKII PKA 
LTCC Enhanced channel opening probability (both), facilitation (CaMKII), and recovery from inactivation (CaMKII); increased fraction of available channels (PKA). 
RyR Enhanced channel opening probability (both) and leak (CaMKII). 
PLB Enhanced Ca-sensitivity of SERCA (both kinases). 
INa 
Shifted current availability towards 
hyperpolarized potentials, delayed recovery 
from inactivation, and enhanced late current 
magnitude (*). 
 
IK1 Decreased current magnitude (*).  
Ito 
Decreased current magnitude and faster 
recovery from inactivation (*).  
IKur  Enhanced current magnitude. 
INaK  
Increased affinity for internal Na, with 
no effect on the maximum pump rate. 
TnI  Decreased TnC affinity for Ca. 
Crosstalk between βAR and CaMKII Signaling in HF 
86 Ph.D. Thesis 
shows a little adaptation of AP duration (APD) as seen in experiments (Wagner et al., 2009). 
The model also reproduces the measured increase of diastolic [Na] with the pacing rate (Fig. 
6B). Analogous to experimental observations, CaT amplitude decreases with increasing 
frequency (Fig. 6C), as a result of increased diastolic and decreased systolic [Ca]i (Fig. 6D). 
Diastolic SR [Ca] is about 105 nmol/L cyt at rest and decreases with pacing until about 80 
nmol/L cyt (at 3 Hz), then is basically unchanged until 8 Hz (not shown). The fractional 
release, measured as the ratio of the twitch to the caffeine-induced CaT, decreases as observed 
by the Sipido group (Antoons et al., 2002). Fig. 6E shows the time to half [Ca]i decay (T50), 
which decreases with the frequency, as experimentally observed, reflecting frequency-
dependent acceleration of relaxation (FDAR). 
 When simulating 6-fold CaMKII-OE, we found a prolongation of the AP (Fig. 7A), in 
agreement with experimental results (Maier et al., 2003; Wagner et al., 2006; Wagner et al., 
2009; Dybkova et al., 2011). This prolongation is mostly due the decrease in Ito expression, 
whereas gain of function in INa and ICa play a limited role (Wagner et al., 2009). CaT 
 
 
 
 
Figure 5. Time course and frequency-dependence of CaMKII phosphorylation. Dyadic CaMKII activity 
(panel A) and phosphorylation levels of LTCC, RyR and PLB (B) during a simulation in CaMKII-OE 
condition in which pacing rates is increased from 0.5 Hz to 2 Hz. Time-averaged steady-state 
phosphorylation levels (C) of LTCC (top) RyR (middle), and PLB (bottom) in control and CaMKII-OE 
conditions. 
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amplitude decreases (Fig. 7B) as a result of RyR phosphorylation that enhances the Ca leak 
thus decreasing the SR Ca content. The same relation has been experimentally observed 
(Maier et al., 2003; Dybkova et al., 2011). In agreement with experimental data (Dybkova et 
al., 2011), [Ca]i decay is slower (Fig. 7C), but FDAR is enhanced by CaMKII-OE effect on 
 
 
 
 
Figure 6. Validation of the model in control condition against a set of experimental data measured at 
different pacing rates. Experimental (symbols) and simulated (solid lines) APD (panel A), diastolic [Na] 
(B), CaT amplitude (C), diastolic and systolic [Ca]i (D), time to half [Ca]i decay (E). All the simulated 
results have been obtained after pacing the digital cell at indicated frequencies until steady-state condition. 
APDX was measured as the interval between AP upstroke and X% repolarization level. Experimental data 
from (Yao et al., 1998; Antoons et al., 2002; Maier et al., 2003; Wagner et al., 2006; Despa et al., 2008; 
Wagner et al., 2009; Li et al., 2010; Dybkova et al., 2011; Li et al., 2011; Li et al., 2012; Edwards et al., 
unpub.). 
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PLB. Fig. 7C shows that the model fails to reflect the increase in [Na] (Wagner et al., 2006), 
revealing an aspect where our quantitative knowledge is complete. 
Consequences of βAR stimulation 
The effect of βAR stimulation has been investigated by simulating the application of 100 nM 
ISO. Fig. 8A shows the ISO-induced rise of cAMP, the second messenger that mediates the 
βAR-induced PKA activation. The model reproduces experimental data about Ca and Na 
handling (Despa et al., 2008): CaT amplitude increases (Fig. 8B), due to phosphorylation at 
LTCC, RyR and PLB, and diastolic [Na] decreases (Fig. 8C) as consequence of PLM 
phosphorylation. 
 We compared the effect of PKA activation in WT and CaMKII-OE conditions, by 
simulating a 120 s long ISO application during 1 Hz stimulation. In agreement with the 
experimental findings (Edwards et al., unpub.) reported in Fig. 9A, the model predicts AP 
prolongation (Fig. 9B), mainly due to the PKA-induced increase of ICa. Our simulations 
confirm the decrease in the diastolic [Ca]i and the increase in CaT amplitude (Fig. 9C). As 
 
 
 
 
Figure 7. Effect of 6-fold CaMKII overexpression. Simulated AP (panel A) and CaT (B) obtained in 
control and CaMKII-OE conditions pacing the virtual cell at 1 Hz; insets show analogous experimental 
recordings. Experimental (symbols) and simulated (solid lines) time to half [Ca]i decay (C) and diastolic 
[Na] (D) at different pacing rates. Experimental data from (Maier et al., 2003; Wagner et al., 2006; Wagner 
et al., 2009; Dybkova et al., 2011). 
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observed in experiments, [Ca]i decay is faster during ISO application, due to phosphorylation 
of PLB. 
 When simulating the PKA activation in CaMKII-OE condition, the model predicts the 
development of delayed afterdepolarizations (DADs, Fig. 10A, black), due to spontaneous SR 
Ca release caused by PKA-induced RyR hyperactivity. This increases [Ca]i (Fig. 10B, black) 
and thus triggers NCX inward current (INaCa, Fig. 10C) that depolarizes the membrane. DADs 
are present both during stimulated beats and when the stimulation is interrupted (Fig. 10A, 
grey). The model does not predict this behavior when simulating the same protocol in WT 
condition (not shown). 
DISCUSSION 
In the present study we developed a novel model of murine ventricular ECC, which integrates 
a detailed Ca-CaM-CaMKII-CaN model (Saucerman & Bers, 2008) and the most recent 
model of PKA-dependent regulation of ECC (Yang & Saucerman, 2012) into a strongly 
validated AP model (Shannon et al., 2004). This is the first model of mouse AP where the two 
pathways are integrated and are described by a fully ODEs system. Our model has been 
identified in the control condition using experimental data recorded (or scaled) at 
physiological temperature, and it faithfully reproduces the frequency response of the main 
features characterizing the mouse myocyte AP and Ca and Na dynamics (Fig. 6).  
 The models also well reproduces the effects of a 6-fold CaMKII-OE (Fig. 7), except 
the observed increase in [Na] in transgenic vs. WT mice (Fig. 7D). Although CaMKII-OE 
increases late INa and sarcolemmal Na leak, these effects are not sufficient to appreciably 
elevate [Na]. This issue has been previously discussed by the Maier and Bers groups (Wagner 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Time course of PKA 
activation. Time course of [cAMP] 
(panel A), [Ca]i (B) and [Na] (C) 
obtained by stimulating the virtual 
cell at 2 Hz in control condition and 
applying 100 nM ISO after 30 s. 
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et al., 2011). In their study the authors aimed to investigate the role of reactive oxygen species 
(ROS) in the contest of HF in mouse. They integrated into the Shannon-Bers model the ROS-
induced increase in late INa, without obtaining a significant increase in [Na], as shown in their 
Online Fig. 1. This may indicate that other mechanisms/pathways are responsible for the 
increase in [Na]. 
 The model well reproduces the effect of 100 nM ISO application (Fig. 8 and Fig. 9) on 
AP and CaT in both control and CaMKII-OE conditions. Moreover, arrhythmogenic activity 
is predicted with contemporary CaMKII and PKA activation: our model shows the 
development of DAD due to spontaneous Ca release from the SR (Fig. 10). In analogous 
experiments (Edwards et al., unpub.), it has been observed the development of early 
afterdepolarizations (EADs, Fig. 11A and C), that are abolished when the SR Ca release is 
prevented by caffeine application (Fig. 11E). It's interesting to underline the important role of 
SR Ca release in both simulated DADs and experimentally observed EADs. Our results 
suggest that this phenomenon may be the trigger mechanism also in the latter case. In our 
 
 
 
 
Figure 9. Effect of ISO application. Experimental data about ISO-induced changes in APD, diastolic [Ca]i, 
CaT amplitude and time constant of [Ca]i decay from (Edwards et al., unpub.) (panel A). Simulated AP (B, 
D) and CaT (C, E) obtained pacing the virtual cell at 1 Hz in absence of ISO (solid lines) and in presence of 
100 nM ISO after a 120 s application (dashed) in WT and CaMKII-OE conditions. 
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simulations SR Ca release (and consequent membrane depolarization) occurs only after the 
resting potential is reached, and this difference with experimental observations may be due to 
an overestimation of PKA effect on a repolarizing current or to an underestimation of the 
effect on a depolarizing current, which can delay the arrhythmogenic event occurrence. 
 Only by introducing drastic modifications (e.g., block of repolarizing currents, 
increase in Ca influx and decrease of pacing frequency), our model reproduces EADs (Fig. 
12A). EAD takeoff is due to spontaneous SR Ca release (Fig. 12B) that causes augmented Ca 
extrusion via NCX. If the depolarization is weak, both Em and [Ca]i smoothly come back to 
the resting value (first beat). On the contrary, if the amplitude is wide enough, ICa reactivates 
(Fig 12C, from second to last beat), facilitating Em depolarization and triggering Ca-induced 
Ca release (CICR); ICa reactivation can also occur more times (e.g., twice in the last beat). Our 
model predicts two different kinds of EAD, with and without ICa reactivation, as 
experimentally seen (Edwards et al., unpub.). The first kind of EAD observed in experiments 
(Fig. 11A) is characterized by a sequence of ICa reactivations. The CaT shows the occurrence 
of several CICR events that forms a kind of plateau (Fig. 11B). The second kind of EAD is 
characterized by more negative take-off potentials (Fig. 11C), any ICa reactivation and no 
CICR. The CaT decay is smooth (Fig. 11D). 
 EADs commonly occur during the plateau phase of the AP, where the balance of 
repolarizing and depolarizing currents keeps Em almost unchanged. A little prolongation of 
the AP may be sufficient to lead to the ICa reactivation that can easily depolarize the 
membrane. The particular morphology of the murine AP does not facilitate the occurrence of 
EAD: the plateau is absent and the repolarization proceeds unhindered. While EADs have 
been often reproduced in many computational studies with AP models of other species, none 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Simulated prediction of DADs 
occurrence as consequences of ISO 
application in CaMKII-OE condition. 
Simulated AP (panel A), CaT (B) and INaCa 
(C) obtained in presence of 100 nM ISO 
after a 120 s application (1 Hz). Black traces 
were obtained by continuing the stimulation 
with the same pacing rate, while grey traces 
were obtained by interrupting the stimulation 
after the first beat. 
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of the mouse AP models described in literature has been applied to study these 
arrhythmogenic events, proof of the difficulty of reproducing EADs with these models. In 
fact, mouse models have been used to study the differences between apex and septum 
(Bondarenko et al., 2004), or between adult and neonatal cell (Wang & Sobie, 2008). Others 
studies investigated the effect of CaMKII phosphorylation (Koivumaki et al., 2009), the 
implications of cardiac NCX overexpression (Li et al., 2010) and of SERCA knockout (Li et 
al., 2011; Li et al., 2012), or studied the implications of PLM knockout (Yang & Saucerman, 
2012). None of these studies showed the simulated development of EADs or DADs. 
 In the past two decades CaMKII has been recognized as being a potential 
proarrhythmic signaling molecule and it has been causally linked to the initiation of triggered 
arrhythmias via both EADs and DADs in mice and other mammals (Anderson, 2007). It is 
assumed that CaMKII-dependent EADs would be attributed to the CaMKII-induced increase 
in late INa or by reactivating ICa, but whether and how these effects quantitatively account for 
EADs is not known. CaMKII effects on RyR increase the propensity for Ca sparks and waves 
(Maier et al., 2003) and these are fundamental events underlying arrhythmogenic DADs. In 
HF, where the NCX may be upregulated (Schillinger et al., 2003) and IK1 downregulated 
 
 
 
 
Figure 11. Experimental observation of EAD as consequences of ISO application in CaMKII-OE mice. 
Different kinds of EAD (panels A, C) and corresponding CaT (B, D) experimentally obtained after 100 nM 
ISO application (Edwards et al., unpub.). EADs are abolished when the SR Ca release is prevented by 
caffeine application (E). 
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(possibly mediated by CaMKII), a given SR Ca release also produces a larger depolarizing 
current and DAD, and the threshold Ca release required to trigger an AP is greatly reduced 
(Pogwizd et al., 2001). It is unknown which of these potential CaMKII effects is predominant 
in causing these arrhythmias, or how they interact with other alterations in failing myocytes to 
increase arrhythmia risk in HF (Pogwizd & Bers, 2004). In this intrigued context, the use of 
mathematical models may be helpful to discriminate the potential effect of the 
phosphorylation of each target, so our model can provide an useful tool to assess which 
CaMKII targets are most arrhythmogenic. 
 There is compelling evidence that CaMKII is a critical downstream target of βAR 
activation in the process of adrenergic-induced hypertrophy and HF (Zhang et al., 2005): 
since CaMKII activity responds to the frequency and magnitude of Ca signals, CaMKII is 
influenced via PKA-dependent enhancement of ICa and SR Ca uptake and, consequently, 
release. However, the details of how the βAR stimulation and CaMKII network interact has 
not been systematically modeled, since there is evidence for a Ca- and PKA-independent 
pathway by which βAR stimulation causes CaMKII activation, RyR activation, inotropy and 
apoptosis (Grimm & Brown, 2010). βAR-induced PKA activation is mediated by cAMP, that 
can also activate the guanine nucleotide exchange factor Epac (independent of PKA) to 
activate CaMKII and RyR-dependent SR Ca leak (Pereira et al., 2007), and this interaction 
has been reported to mediate βAR-induced cardiac hypertrophy (Metrich et al., 2008). 
Moreover, it has been shown that the βAR activation of CaMKII, which is Ca- and PKA-
independent, is also cAMP-independent (Curran et al., 2007). It has also been shown that 
 
 
 
 
Figure 12. Simulation of EADs. Simulated Em (panel A), CaT (B) and ICa (C) obtained during a 100 nM 
ISO application at a pacing rate of 0.33 Hz. Repolarizing currents were drastically reduced and conductance 
of ICa and background INa increased. 
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ROS, increased in HF, can contribute to increase late INa (leading to intracellular Na 
accumulation and arrhythmias), and, above all, can activate CaMKII via oxidation (Erickson 
et al., 2008). Given the complexity of this system and of all the mechanisms involved, it is 
hard to imagine to integrate detailed descriptions of all these pathways in our model, that 
could be certainly extended and improved. Rather, our model could provide an useful tool for 
experiment planning, since preliminary results obtained by integrating simplified effect could 
give rise to hypotheses and address future experimental work. 
Conclusion 
A novel model of murine ECC has been identified at physiological temperature and validated 
at baseline. It improves existing murine AP models by including the most recent descriptions 
of CaMKII (Saucerman & Bers, 2008) and PKA (Yang & Saucerman, 2012) signaling 
pathways. This allowed investigating the effects of contemporary activation of the two 
pathways and showing how PKA activation results in triggered activity in the context of 
CaMKII-OE. 
 We conclude that our model is a useful quantitative tool to examine at the single cell 
level how CaMKII and PKA signaling pathways interact to coordinate ECC in the context of 
HF. For example, it can be used to test which CaMKII targets are most arrhythmogenic or to 
assess the effects of acute vs. chronic CaMKII hyperactivity. Given its computational 
tractability, it could be incorporated in tissue-scale/whole heart models to test how these 
cellular instabilities can induce arrhythmias. This model could also be an useful tool for the 
potential interaction with experiment planning. Moreover, a systematic framework accounting 
for electrophysiological differences among species could be developed to extrapolate findings 
in the genetically engineered mice to the clinical setting. 
 Further work will be required to incorporate modulation of CaMKII by other 
mechanisms involved in its regulation, such as ROS activation and βAR-induced Ca- and 
PKA-independent activation pathways. 
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CONCLUSION 
My research activity has been focusing on the development of mathematical tools for 
investigating the mechanisms underlying ventricular excitation-contraction coupling (ECC), 
that is the process linking the electrical behavior of the membrane to the mechanical 
contraction of the myofilaments in myocytes (Bers, 2001), via the intracellular Ca signal. 
Three research projects have been presented in this thesis, in which computational modeling 
(at the single cell level) is applied to the study of cardiac electrophysiology. 
 The first study was aimed at simulating the effect of the Na channel blocker mexiletine 
on mutant cardiac Na current (INa), which led to unpredicted QT interval prolongation in a 
long QT syndrome type 3 (LQT3) patient (Ruan et al., 2010). A Markov model of INa (Clancy 
& Rudy, 2002) was tuned to reproduce the experimentally observed effect of the F1473S Na 
channel mutation, and the modulatory effect of mexiletine. In collaboration with the Priori 
group, we provided evidence that this drug facilitates trafficking of the mutant Na channel 
(but not the wild type), thus prolonging QT interval and worsening arrhythmias. Our findings 
suggest that caution should be used when recommending Na channel blockers (commonly 
considered a gene-specific therapy for LQT3 patients) to carriers of mutations with undefined 
electrophysiological properties. We propose that functional characterization of mutant 
currents may guide mutation-specific treatment, and in silico analysis may be used to 
personalize therapy for LQT3 patients. 
 In the second project we studied the inactivation kinetics of the cardiac L-type Ca 
current (ICa), in order to faithfully describe the relative contributions of the two mechanisms 
of Ca- and voltage-dependent inactivation (CDI and VDI) (Grandi et al., 2010; Morotti et al., 
2012). Moreover, the formulation of sarcoplasmic reticulum (SR) Ca release was modified to 
ensure proper Ca-dependent modulation of ICa inactivation at negative membrane potentials, 
where ECC gain is high. From our analysis we concluded that the inactivation of the non 
specific monovalent current (carried by Na and Cs) through LTCCs does not resemble VDI in 
physiological conditions. Next, we identified Markov model of ICa (Mahajan et al., 2008) 
based on a broad range of experimental data on channel permeability and gating, and 
validated it against functional data in various homeostasis conditions. By taking into account 
a small contribution of ion-dependent inactivation (in addition to pure VDI) when Ba is the 
charge carrier, our model faithfully reproduced the relative importance of VDI and CDI to 
total ICa inactivation. Ba-dependent inactivation was usually neglected by other modeling 
studies and led to overestimation of VDI. Thus, we provided a useful tool to study the role of 
ICa kinetics during normal and altered repolarization. 
Conclusion 
102 Ph.D. Thesis 
 β-adrenergic (βAR) and Ca-calmodulin dependent protein kinase (CaMKII) activation 
was modeled to understand how the crosstalk between these signaling pathways influences 
ECC in the context of heart failure (HF). This required the reparameterization of an action 
potential (AP) model, whereby cell geometry, ion currents, Ca and Na handling were adapted 
to murine electrophysiology. Furthermore, the regulatory effects of CaMKII signaling 
pathway and βAR activation were integrated into the AP model, based on existing 
descriptions (Saucerman & Bers, 2008; Yang & Saucerman, 2012). This provides a useful 
quantitative framework to examine how CaMKII and βAR signaling pathways interact to 
coordinate ECC and arrhythmias in the context of HF (e.g., to test which CaMKII targets are 
most arrhythmogenic), and could serve as the basis for a systematic framework to extrapolate 
findings in animals to humans and the clinical setting. 
 In fact, while this last project was based on the development of a novel murine ECC 
model, a human model (ten Tusscher & Panfilov, 2006) was used to study the effects on the 
AP of the mutant INa, and a rabbit model (Shannon et al., 2004) served as the basis for the 
study of ICa inactivation. The main differences between rabbit and mouse APs (and the 
underlying mechanisms) are described in detail in the third chapter. Briefly, mouse AP lacks a 
plateau phase, but exhibits rapid repolarization and very short AP duration (APD), if 
compared with the prominent plateau phase and long AP seen in rabbit (and in human as 
well). These differences are mainly due to different expression of membrane proteins (in 
particular, K channels). The development of this kind of species-specific models highlights 
marked electrophysiological differences among various species, which may underlie different 
arrhythmia mechanisms, and are crucial when trying to extrapolate experimental results in 
animals to human (e.g., effect of disease-induced remodeling or response to drugs). 
 
 
 
 
 
Figure 1. Mechanisms underlying afterdepolarizations. During the DAD (first column) SR 
Ca release activates INaCa that, in one case (solid line), is sufficient to bring the myocyte to the 
threshold and an AP can be triggered and, in the other case (dashed), is not. The second column 
shows a situation where the EAD is initiated by SR Ca release and NCX activity, while the EAD 
shown in the third column is initiated by ICa reactivation. Modified from (Bers, in press). 
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 Ultimately, we aimed at using our computational methods to provide insights into the 
mechanisms underlying cardiac arrhythmias. When simulating the effects of the Na channel 
mutation F1473S, we predicted AP prolongation, which is associated with the prolongation of 
the QT interval seen on the patient's ECG (and characterizing the LQT3 phenotype). This AP 
prolongation (maximal at slow heart rates) facilitates the occurrence of early 
afterdepolarizations (EADs). In fact, long QT syndrome patients experience arrhythmogenic 
events preferentially at rest. Moreover, when simulating the effects of mexiletine 
administration, we observed further AP prolongation, leading to capture failures at fast heart 
rates. 
 We confirmed that LTCC inactivation is an important feedback mechanism that 
regulates Ca loading and duration of repolarization. When simulating the inhibition of VDI 
(in order to mimic Timothy syndrome), we obtained a prolongation of the AP. More drastic 
consequences were obtained when reducing CDI, thus suggesting that CDI is dominant (vs. 
VDI) in physiological conditions. We simulated the expression of a mutant calmodulin 
(unable to mediate CDI) and predicted the occurrence of phase 2 EADs. These have been 
commonly associated to ICa reactivation (January & Riddle, 1989; Luo & Rudy, 1994), but 
our modeling works showed that the reduction in CDI causes intracellular Ca overload and 
thus spontaneous SR Ca release, which enhances inward Na-Ca exchange current (INaCa) that 
depolarizes the membrane (Fig. 1, second column). The same triggering mechanism was 
found responsible for delayed afterdepolarizations (DADs) obtained by a further increase in 
mutant calmodulin expression (i.e. stronger inhibition of CDI) in rabbit, and by contemporary 
activation of βAR and CaMKII signaling pathways in our murine ECC model. Our LTCC 
model predicts phase 2 EADs due to ICa reactivation when simulating the effect of K currents 
block (Fig. 1, third column), as experimentally observed. In this case, the inhibition of 
repolarizing currents prolongs the AP, allowing the reactivation of some LTCCs and thus 
creating an inward current surge and net depolarization. We also demonstrated that the two 
triggering mechanisms are not mutually exclusive. For example, the SR Ca release-triggered 
NCX activity may produce only a very small depolarization that may then be amplified by 
recruiting ICa to cause a larger EAD, as we implied in simulating the crosstalk between βAR 
and CaMKII signaling in HF. 
 In conclusion, the present thesis shows how mathematical approach is suitable to 
provide new insights into the mechanisms controlling cardiac ECC in physiological and 
pathological conditions. 
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